# EDGAR Filing Document

**Accession Number:** 0001750735
**File Stem:** 0001750735-26-000050
**Filing Date:** 2026-5
**Character Count:** 203423
**Document Hash:** ed5c7f9759b7247573ee4ce17513ba12
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001750735-26-000050.hdr.sgml**: 20260511

**ACCESSION NUMBER**: 0001750735-26-000050

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 82

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260511

**DATE AS OF CHANGE**: 20260511

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Meridian Corp
- **CENTRAL INDEX KEY:** 0001750735
- **STANDARD INDUSTRIAL CLASSIFICATION:** NATIONAL COMMERCIAL BANKS [6021]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 831561918
- **STATE OF INCORPORATION:** PA
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-55983
- **FILM NUMBER:** 26961832

**BUSINESS ADDRESS:**
- **STREET 1:** 9 OLD LINCOLN HIGHWAY
- **CITY:** MALVERN
- **STATE:** PA
- **ZIP:** 19355
- **BUSINESS PHONE:** 484-568-5000

**MAIL ADDRESS:**
- **STREET 1:** 9 OLD LINCOLN HIGHWAY
- **CITY:** MALVERN
- **STATE:** PA
- **ZIP:** 19355

?xml version='1.0' encoding='ASCII'? mrbk-20260331

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q**

(Mark one)

**☒** QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2026

Or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number: **000-55983**

![MeridianCorporation.jpg](mrbk-20260331_g1.jpg)

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **<u>Pennsylvania</u>** | **<u>83-1561918</u>** |
| (State or other jurisdiction of<br>incorporation or organization) | (I.R.S. Employer Identification No.) |

---

**<u>9 Old Lincoln Highway, Malvern, Pennsylvania 19355</u>**

(Address of principal executive offices) (Zip Code)

**(<u>484</u>) <u>568-5000</u>**

(Registrant's telephone number, including area code)

---

| | | |
|:---|:---|:---|
| **<u>Title of class</u>** | **<u>Trading Symbol</u>** | **<u>Name of exchange on which registered</u>** |
| Common Stock, $1 par value | MRBK | The NASDAQ Stock Market |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. **☒**Yes ☐No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). **☒**Yes ☐No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large Accelerated Filer | ☐ | Accelerated Filer | ☒ |
| Non-accelerated Filer | ☐ | Smaller Reporting Company | ☒ |
| Emerging Growth Company | ☐ | | |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date. As of May 7, 2026 there were 11,890,278 outstanding shares of the issuer's common stock, par value $1.00 per share.

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

**TABLE OF CONTENTS**

---

| | |
|:---|:---|
| **[PART I FINANCIAL INFORMATION](#i35a1119feabe45df9d3857a088023686_13)** | |
| [Item 1 Financial Statements (Unaudited)](#i35a1119feabe45df9d3857a088023686_16) | [3](#i35a1119feabe45df9d3857a088023686_16) |
| [Consolidated Balance Sheets –](#i35a1119feabe45df9d3857a088023686_19)March 31, 2026 [and](#i35a1119feabe45df9d3857a088023686_19)December 31, 2025 | [3](#i35a1119feabe45df9d3857a088023686_19) |
| [Consolidated Statements of Income –](#i35a1119feabe45df9d3857a088023686_22)Three[Months Ended](#i35a1119feabe45df9d3857a088023686_22)March 31, 2026[and](#i35a1119feabe45df9d3857a088023686_22)2025 | [4](#i35a1119feabe45df9d3857a088023686_22) |
| [Consolidated Statements of Comprehensive Income –](#i35a1119feabe45df9d3857a088023686_25)Three[Months Ended](#i35a1119feabe45df9d3857a088023686_22)March 31, 2026[and](#i35a1119feabe45df9d3857a088023686_22)2025 | [5](#i35a1119feabe45df9d3857a088023686_25) |
| [Consolidated Statements of Stockholders' Equity –](#i35a1119feabe45df9d3857a088023686_28)Three[Months Ended](#i35a1119feabe45df9d3857a088023686_22)March 31, 2026[and](#i35a1119feabe45df9d3857a088023686_22)2025 | [6](#i35a1119feabe45df9d3857a088023686_28) |
| [Consolidated Statements of Cash Flows –](#i35a1119feabe45df9d3857a088023686_34)Three Months EndedMarch 31, 2026[and](#i35a1119feabe45df9d3857a088023686_34)2025 | [7](#i35a1119feabe45df9d3857a088023686_34) |
| [Notes to Consolidated Financial Statements (Unaudited)](#i35a1119feabe45df9d3857a088023686_37) | [8](#i35a1119feabe45df9d3857a088023686_37) |
| [Item 2 Management's Discussion and Analysis of Financial Condition and Results of Operations](#i35a1119feabe45df9d3857a088023686_94) | [33](#i35a1119feabe45df9d3857a088023686_94) |
| [Item 3 Quantitative and Qualitative Disclosures about Market Risk](#i35a1119feabe45df9d3857a088023686_154) | [45](#i35a1119feabe45df9d3857a088023686_154) |
| [Item 4 Controls and Procedures](#i35a1119feabe45df9d3857a088023686_157) | [46](#i35a1119feabe45df9d3857a088023686_157) |
| **[PART II OTHER INFORMATION](#i35a1119feabe45df9d3857a088023686_160)** |  |
| [Item 1 Legal Proceedings](#i35a1119feabe45df9d3857a088023686_163) | [46](#i35a1119feabe45df9d3857a088023686_163) |
| [Item 1A Risk Factors](#i35a1119feabe45df9d3857a088023686_166) | [46](#i35a1119feabe45df9d3857a088023686_166) |
| [Item 2 Unregistered Sales of Equity Securities and Use of Proceeds](#i35a1119feabe45df9d3857a088023686_169) | [46](#i35a1119feabe45df9d3857a088023686_169) |
| [Item 3 Defaults Upon Senior Securities](#i35a1119feabe45df9d3857a088023686_172) | [46](#i35a1119feabe45df9d3857a088023686_172) |
| [Item 4 Mine Safety Disclosures](#i35a1119feabe45df9d3857a088023686_175) | [46](#i35a1119feabe45df9d3857a088023686_175) |
| [Item 5 Other Information](#i35a1119feabe45df9d3857a088023686_178) | [46](#i35a1119feabe45df9d3857a088023686_178) |
| [Item 6 Exhibits](#i35a1119feabe45df9d3857a088023686_181) | [47](#i35a1119feabe45df9d3857a088023686_181) |
| [Signatures](#i35a1119feabe45df9d3857a088023686_187) | [48](#i35a1119feabe45df9d3857a088023686_187) |

---

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

**Glossary of Acronyms, Abbreviations, and Terms**

The acronyms, abbreviations, and terms listed below are used in various sections of this report. As used throughout this report, the terms "Meridian", "we", "our", or "us" refer to Meridian Corporation and its consolidated subsidiaries, unless the context otherwise requires.

---

| | |
|:---|:---|
| **Acronym** | **Description** |
| ACBB | Atlantic Central Bankers Bank |
| ACH | Automated clearing house |
| ACL | Allowance for credit losses |
| AFS | Available-for-sale |
| AI | Artificial intelligence |
| ALCO | Asset/Liability Committee |
| ALM | Asset / liability management |
| AOCI | Accumulated other comprehensive income |
| ASC | Accounting Standards Codification |
| ASU | Accounting Standards Update |
| ATM | At the Market common stock offering |
| BHC Act | Bank Holding Company Act of 1956 |
| BOLI | Bank owned life insurance |
| BSA-AML | Bank Secrecy Act - Anti-Money Laundering |
| BTFP | Federal Reserve Bank Term Funding Program |
| CBCA | Change in Bank Control Act |
| CBLR | Community Bank Leverage Ratio |
| CDARS | Certificate of Deposit Account Registry Service |
| CECL | Current expected credit losses |
| CET1 | Common equity tier 1 |
| CFPB | Consumer Financial Protection Bureau |
| CMO | Collateralized mortgage obligation |
| CODM | Chief Operating Decision Maker |
| CRE | Commercial real estate |
| DIF | FDIC's deposit insurance fund |
| ECOA | Equal Credit Opportunity Act |
| ESOP | Employee Stock Ownership Plan |
| FASB | Financial Accounting Standards Board |
| FDIA | Federal Deposit Insurance Act |
| FDIC | Federal Deposit Insurance Corporation |
| FED | Federal Reserve System |
| FFIEC | Federal Financial Institutions Examination Council |
| FHA | Federal Housing Authority |
| FHFA | Federal Housing Finance Agency |
| FHLB | Federal Home Loan Bank of Pittsburgh |
| FHLMC | Federal Home Loan Mortgage Corporation or Freddie Mac |
| FICO | Financing Corporation |
| FNMA | Federal National Mortgage Association or Fannie Mae |
| FRB | Federal Reserve Bank of Philadelphia |
| FTE | Fully taxable equivalent |
| GAAP | U.S. generally accepted accounting principles |
| GLB Act | Gramm-Leach-Bliley Act |
| GNMA | Government National Mortgage Association or Ginnie Mae |
| GSE | Government-sponsored entities |
| HTM | Held-to-maturity |

---

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

---

| | |
|:---|:---|
| ICBA | Independent Community Bankers of America |
| JOBS Act | Jumpstart Our Business Startups Act of 2012 |
| LBP | Look-back period |
| LEP | Loss emergence period |
| LIBOR | London Inter-bank Offering Rate |
| LIHTC | Low-income-housing tax credit |
| MBS | Mortgage-backed securities |
| MSLP | Main Street Lending Programs |
| MSR | Mortgage servicing rights |
| NSFR | Net stable funding ratio |
| OFAC | Office of Foreign Assets Control |
| OREO | Other real estate owned |
| PCAOB | Public Company Accounting Oversight Board |
| PCD | Purchased credit deteriorated |
| PD | Probability of default |
| PDBS | Pennsylvania Department of Banking and Securities |
| ROU | Right-of-use |
| SBA | Small Business Administration |
| SEC | Securities and Exchange Commission |
| SERP | Supplemental Executive Retirement Plan |
| SNC | Shared national credit |
| SOFR | Secure Overnight Financing Rate |
| TILA | Truth in Lending Act |
| TDR | Troubled debt restructuring |
| USDA | U.S. Department of Agriculture |
| VA | U.S. Department of Veteran's Affairs |

---

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

**MERIDIAN CORPORATION AND SUBSIDIARIES**

**CONSOLIDATED BALANCE SHEETS**

(Unaudited)

---

| | | |
|:---|:---|:---|
| *(dollars in thousands, except share data)* | **March 31,<br>2026** | **December 31,<br>2025** |
| **Assets:** |  |  |
| Cash and due from banks | $12458 | $10358 |
| Interest-bearing deposits at other banks | 15811 | 25420 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | 28269 | 35778 |
| Securities available-for-sale, at fair value (amortized cost of $202,419 and $199,127, respectively) | 196012 | 193457 |
| Securities held-to-maturity, at amortized cost (fair value of $29,914 and $30,152, respectively) | 32494 | 32544 |
| Equity investments | 2137 | 2166 |
| Mortgage loans held for sale | 38960 | 33762 |
| Loans and other finance receivables, net of fees and costs | 2181575 | 2170600 |
| Allowance for credit losses | (21252) | (21573) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loans and other finance receivables, net of the allowance for credit losses | 2160323 | 2149027 |
| Restricted investment in bank stock | 7699 | 7811 |
| Bank premises and equipment, net | 12298 | 12402 |
| Bank owned life insurance | 30959 | 30687 |
| Accrued interest receivable | 11015 | 10724 |
| OREO and other repossessed assets | 6009 | 5997 |
| Deferred income taxes | 4548 | 4215 |
| Servicing assets | 3694 | 3932 |
| Goodwill | 899 | 899 |
| Intangible assets | 2512 | 2563 |
| Other assets | 38753 | 36031 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $2576581 | $2561995 |
| **Liabilities:** |  |  |
| Deposits: |  |  |
| Non-interest bearing | $243458 | $245377 |
| Interest bearing | 1926502 | 1912751 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total deposits | 2169960 | 2158128 |
| Borrowings | 120838 | 117338 |
| Subordinated debentures | 49675 | 49853 |
| Accrued interest payable | 6620 | 6531 |
| Other liabilities | 29263 | 30429 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 2376356 | 2362279 |
| **Stockholders' equity:** |  |  |
| Common stock, $1 par value: 25,000,000 shares authorized; 13,882,361 and 13,829,645 shares issued, respectively, and 11,879,178 and 11,826,462 shares outstanding, respectively | 13882 | 13830 |
| Surplus | 90885 | 90352 |
| Treasury stock, 2,003,183 shares, at cost | (26079) | (26079) |
| Unearned common stock held by ESOP | (1232) | (1232) |
| Retained earnings | 128472 | 128124 |
| Accumulated other comprehensive loss | (5703) | (5279) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | 200225 | 199716 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and stockholders' equity | $2576581 | $2561995 |

---

See accompanying notes to the unaudited consolidated financial statements.

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

**MERIDIAN CORPORATION AND SUBSIDIARIES**

**CONSOLIDATED STATEMENTS OF INCOME**

(Unaudited)

---

| | | |
|:---|:---|:---|
| | **Three months ended**<br>**March 31,** | **Three months ended**<br>**March 31,** |
| *(dollars in thousands, except per share data)* | **2026** | **2025** |
| **Interest income:** |  |  |
| Loans and other finance receivables, including fees | $38144 | $36549 |
| Securities - taxable | 1847 | 1693 |
| Securities - tax-exempt | 323 | 313 |
| Cash and cash equivalents | 398 | 613 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total interest income | 40712 | 39168 |
| **Interest expense:** |  |  |
| Deposits | 15223 | 16868 |
| Borrowings and subordinated debentures | 2287 | 2524 |
| &nbsp;&nbsp;&nbsp;&nbsp; Total interest expense | 17510 | 19392 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net interest income | 23202 | 19776 |
| Provision for credit losses | 7493 | 5212 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net interest income after provision for credit losses | 15709 | 14564 |
| **Non-interest income:** |  |  |
| Mortgage banking income | 4528 | 3393 |
| Wealth management income | 1729 | 1535 |
| SBA loan income | 150 | 748 |
| Earnings on investment in life insurance | 272 | 222 |
| Net loss on sale of MSRs | (159) | (52) |
| Net change in the fair value of derivative instruments | (51) | 149 |
| Net change in the fair value of loans held-for-sale | (380) | 102 |
| Net change in the fair value of loans held-for-investment | (39) | 170 |
| Net gain on hedging activity | 18 | 21 |
| Other | 969 | 1036 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total non-interest income | 7037 | 7324 |
| **Non-interest expense:** |  |  |
| Salaries and employee benefits | 12386 | 11385 |
| Occupancy and equipment | 1183 | 1338 |
| Professional fees | 974 | 763 |
| Data processing and software | 1973 | 1479 |
| Advertising and promotion | 692 | 779 |
| Pennsylvania bank shares tax | 258 | 269 |
| Other | 2692 | 2730 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total non-interest expense | 20158 | 18743 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income before income taxes | 2588 | 3145 |
| Income tax expense | 582 | 746 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income | $2006 | $2399 |
| Basic earnings per common share | $0.17 | $0.21 |
| Diluted earnings per common share | $0.17 | $0.21 |
| Basic weighted average shares outstanding | 11811 | 11205 |
| Diluted weighted average shares outstanding | 12153 | 11446 |

---

See accompanying notes to the unaudited consolidated financial statements.

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

**MERIDIAN CORPORATION AND SUBSIDIARIES**

**CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME** 

(Unaudited)

---

| | | |
|:---|:---|:---|
| | **Three months ended<br>March 31,** | **Three months ended<br>March 31,** |
| *(dollars in thousands)* | **2026** | **2025** |
| Net income: | $2006 | $2399 |
| Net change in unrealized (losses) gains on investment securities available for sale: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of investment securities, net of tax of $(166) and $202, respectively | (570) | 699 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reclassification adjustment for investment securities transferred to held-to-maturity, net of tax effect of $7 and $7, respectively | 24 | 22 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrealized investment (losses) gains, net of tax effect of $(159) and $210, respectively | $(546) | $721 |
| Net change in unrealized gains (losses) on interest rate swaps used in cash flow hedges, net of tax effect of $(36) and $(192), respectively | 122 | (192) |
| Total other comprehensive (loss) income | $(424) | $529 |
| Total comprehensive income | $1582 | $2928 |

---

See accompanying notes to the unaudited consolidated financial statements.

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

**MERIDIAN CORPORATION AND SUBSIDIARIES**

**CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY**

(Unaudited)

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| *(dollars in thousands, except per share data)* | **Common**<br>**Stock** | **Surplus** | **Treasury<br>Stock** | **Unearned<br>ESOP** | **Retained<br>Earnings** | **AOCI** | **Total** |
| **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** |  |  |  |  |  |  |
| Balance at January 1, 2026 | $13830 | $90352 | $(26079) | $(1232) | $128124 | $(5279) | $199716 |
| Net income |  |  |  |  | 2006 |  | 2006 |
| Other comprehensive loss |  |  |  |  |  | (424) | (424) |
| Dividends declared ($0.140 per share) |  |  |  |  | (1658) |  | (1658) |
| Common stock issued through share-based awards and exercises | 52 | 565 |  |  |  |  | 617 |
| Stock based compensation (benefit) |  | (32) |  |  |  |  | (32) |
| Balance at March 31, 2026 | $13882 | $90885 | $(26079) | $(1232) | $128472 | $(5703) | $200225 |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| *(dollars in thousands, except per share data)* | **Common**<br>**Stock** | **Surplus** | **Treasury<br>Stock** | **Unearned<br>ESOP** | **Retained<br>Earnings** | **AOCI** | **Total** |
| **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** |  |  |  |  |  |  |
| Balance at January 1, 2025 | $13243 | $81545 | $(26079) | $(1006) | $111961 | $(8142) | $171522 |
| Net income |  |  |  |  | 2399 |  | 2399 |
| Other comprehensive income |  |  |  |  |  | 529 | 529 |
| Dividends declared ($0.125 per share) |  |  |  |  | (1408) |  | (1408) |
| Common stock issued through share-based awards and exercises | 45 | 363 |  |  |  |  | 408 |
| Stock based compensation expense |  | 118 |  |  |  |  | 118 |
| Balance at March 31, 2025 | $13288 | $82026 | $(26079) | $(1006) | $112952 | $(7613) | $173568 |

---

See accompanying notes to the unaudited consolidated financial statements.

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

**MERIDIAN CORPORATION AND SUBSIDIARIES**

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

(Unaudited)

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
| *(dollars in thousands)* | **2026** | **2025** |
| Net income | $2006 | $2399 |
| **Adjustments to reconcile net income to net cash provided by operating activities:** |  |  |
| &nbsp;&nbsp;&nbsp;Net amortization of investment premiums and discounts and change in fair value of equity securities | 91 | 1069 |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization (accretion), net | 25 | 6 |
| &nbsp;&nbsp;&nbsp;Provision for credit losses | 7493 | 5212 |
| &nbsp;&nbsp;&nbsp;Amortization of issuance costs on subordinated debt | 32 | 31 |
| &nbsp;&nbsp;&nbsp;Stock based compensation | (32) | 118 |
| &nbsp;&nbsp;&nbsp;Net change in fair value of derivative instruments | 51 | (149) |
| &nbsp;&nbsp;&nbsp;Net change in fair value of loans held for sale | 380 | (102) |
| &nbsp;&nbsp;&nbsp;Net change in fair value of loans held for investment | 39 | (170) |
| &nbsp;&nbsp;&nbsp;Amortization and net impairment of servicing rights | 79 | 274 |
| &nbsp;&nbsp;&nbsp;Net loss on sale of MSRs | 159 | 52 |
| &nbsp;&nbsp;&nbsp;SBA loan income | (150) | (748) |
| &nbsp;&nbsp;&nbsp;Proceeds from sale of loans | 167141 | 148087 |
| &nbsp;&nbsp;&nbsp;Loans originated for sale | (168191) | (140455) |
| &nbsp;&nbsp;&nbsp;Mortgage banking income | (4528) | (3393) |
| &nbsp;&nbsp;&nbsp;Increase in accrued interest receivable | (291) | (387) |
| &nbsp;&nbsp;&nbsp;Increase (decrease) in other assets | (47) | 4317 |
| &nbsp;&nbsp;&nbsp;Earnings from investment in bank owned life insurance | (272) | (222) |
| &nbsp;&nbsp;&nbsp;Increase in deferred income tax | (207) | (646) |
| &nbsp;&nbsp;&nbsp;Increase in accrued interest payable | 89 | 544 |
| &nbsp;&nbsp;&nbsp;(Decrease) increase in other liabilities | (1004) | 2280 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net cash provided by operating activities | 2863 | 18117 |
| **Cash flows from investing activities:** |  |  |
| Activity in available-for-sale securities: |  |  |
| Maturities, repayments and calls | 5153 | 3198 |
| Purchases | (8270) | (14274) |
| Activity in held-to-maturity securities: |  |  |
| Maturities, repayments and calls |  | 999 |
| Proceeds from sale of loans held for investment | 6698 | 12138 |
| Net redemptions (purchases) of restricted investments in bank stocks | 112 | (616) |
| Net increase in loans | (27919) | (53020) |
| Purchases of premises and equipment | (227) | (259) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net cash used in investing activities | (24453) | (51834) |
| **Cash flows from financing activities:** |  |  |
| Net increase in deposits | 11832 | 123374 |
| Increase in short-term borrowings | 3500 | 6184 |
| Increase in long-term debt |  | 8935 |
| Repayment of subordinated debt | (210) | (13) |
| Dividends paid | (1658) | (1408) |
| Stock based awards and exercises | 617 | 408 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net cash provided by financing activities | 14081 | 137480 |
| Net change in cash and cash equivalents | (7509) | 103763 |
| Cash and cash equivalents at beginning of period | 35778 | 27462 |
| Cash and cash equivalents at end of period | $28269 | $131225 |
| **Supplemental disclosure of cash flow information:** |  |  |
| Cash paid during the period for: |  |  |
| Interest | $17421 | $18848 |
| Income taxes: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;State | 299 |  |
| Total Income taxes | 299 |  |
| Net loans sold, not settled | 2955 | (1834) |

---

See accompanying notes to the unaudited consolidated financial statements.

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

**MERIDIAN CORPORATION AND SUBSIDIARIES**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Unaudited)**

**(1)&nbsp;&nbsp;&nbsp;&nbsp;Summary of Significant Accounting Policies**

**Basis of Presentation**

The Corporation's unaudited consolidated financial statements have been prepared in accordance with U.S. GAAP for interim financial information. Accordingly, they do not include all of the information and footnotes required by GAAP for complete consolidated financial statements. In the opinion of management, all adjustments necessary for a fair presentation of the consolidated financial position and the results of operations for the interim periods presented have been included.

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Amounts subject to significant estimates are items such as the allowance for credit losses, lending related commitments and the related unfunded commitment reserve, the fair value of financial instruments, other-than-temporary impairments of investment securities, and the valuations of goodwill, intangible assets, and servicing assets.

These unaudited consolidated financial statements should be read in conjunction with the Corporation's filings with the SEC (including our Annual Report on Form 10-K for the year ended December 31, 2025), subsequently filed quarterly reports on Form 10-Q and current reports on Form 8-K that update or provide information in addition to the information included in Form 10-K and Form 10-Q filings, if any.

Certain prior period amounts have been reclassified to conform with current period presentation. Reclassifications had no effect on net income or stockholders' equity. Operating results for the three months ended March 31, 2026 are not necessarily indicative of the results for the year ending December 31, 2026 or for any other period.

**Recent Accounting Pronouncements**

***Pronouncements Adopted as of March 31, 2026:***

The following pronouncements were adopted in 2026, but did not have a material impact on our consolidated financial statements.

**FASB ASU 2024-04, "Debt with Conversion and Other Options (Subtopic 470-20)"**

The amendments in the ASU clarify the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as an induced conversion. The amendments in the ASU are effective for all entities for annual reporting periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods. The adoption of this guidance did not have a material impact on the Corporation's consolidated financial statements.

***Pronouncements Not Yet Effective as of March 31, 2026:***

**FASB ASU No. 2023-06, "Disclosure Improvements: Codification Amendments in Response to the SEC's Disclosure Update and Simplification Initiative".**

This ASU amends the disclosure or presentation requirements related to various subtopics in the ASC. The amendments are expected to clarify or improve disclosure and presentation requirements of a variety of Codification Topics, allow users to more easily compare entities subject to the SEC's existing disclosures with those entities that were not previously subject to the requirements, and align the requirements in the Codification with the SEC's regulations. For entities subject to the SEC's existing disclosure requirements the effective date for each amendment will be the date on which the SEC removes that related disclosure from its rules. For all other entities, the amendments will be effective two years later. However, if by June 30, 2027, the SEC has not removed the related disclosure from its regulations, the amendments will be removed from the Codification and not become effective for any entity.

**FASB ASU 2024-03, "Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40)"** 

This amendment requires enhanced disaggregation of certain expense categories within the income statement to provide more detailed information about the nature and function of expenses. The objective is to improve the transparency and usefulness of financial statements for users by offering greater insight into the components of operating expenses. The amendments in this update are effective for fiscal years beginning after December 15, 2026. These changes may be applied prospectively or retroactively. Early adoption is permitted. The Corporation is currently evaluating the impact of such amendments to the consolidated financial statements and related disclosures.

**FASB ASU 2025-01, "Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date"** 

This amendment addresses questions that were raised regarding the effective date of ASU 2024-03 for public business entities with non-calendar year ends. The amendment clarifies that all public business entities are required to adopt the guidance in annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The Corporation is currently evaluating the impact of such amendments to the consolidated financial statements and related disclosures.

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

**FASB ASU 2025-06, "Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40)."**

This update modernizes internal-use software guidance to apply regardless of the method used to develop software. The amendment will be effective for annual reporting periods beginning after December 15, 2027, and interim reporting periods within those annual reporting periods. Early adoption is permitted as of the beginning of an annual reporting period. The Corporation is currently evaluating the impact of such amendments to the consolidated financial statements and related disclosures.

**FASB ASU 2025-07, "Derivatives and Hedging (Topic 815) and Revenue from Contracts with Customers (Topic 606) – Derivatives Scope Refinements and Scope Clarification for Share-Based Noncash Consideration from a Customer in a Revenue Contract"**

This update refines the scope of Topic 815 to clarify which contracts are subject to derivative accounting and clarifies guidance under Topic 606 for share-based noncash consideration from a customer in revenue contracts. The amendments in this update are effective for annual reporting periods beginning after December 15, 2026. The Corporation is currently evaluating the impact of such amendments to the consolidated financial statements and related disclosures.

**FASB ASU 2025-08, "Financial Instruments - Credit Losses (Topic 326): Purchased Loans".** 

This ASU changes the accounting for certain acquired loans by requiring entities to apply a "gross-up" approach at acquisition for purchased seasoned loans, recognizing an allowance for credit losses as part of the acquisition accounting rather than through a post-acquisition provision. The amendments are to be applied prospectively to loans acquired on or after the initial application date. The ASU will be effective for the annual reporting period beginning after December 15, 2026. Early adoption is permitted. The Corporation is currently evaluating the impact of such amendments to the consolidated financial statements and related disclosures.

**FASB ASU 2025-11, "Interim Reporting (Topic 270) Narrow-Scope Improvements."**

This ASU clarifies when Topic 270 applies and enhances usability by (among other changes) specifying the form/content of interim financial statements, providing a comprehensive list of required interim disclosures, and introducing a disclosure principle for material events since the last annual period-without intending to significantly expand or reduce interim disclosure requirements. The amendments in this update are effective for the annual reporting period beginning after December 15, 2027. The Corporation is currently evaluating the impact of such amendments to the consolidated financial statements and related disclosures.

**FASB ASU 2025-12, "Codification Improvements."** 

This ASU is part of the FASB's standing "evergreen" project and makes a broad set of technical corrections, clarifications, and other minor improvements across many Topics to make the Codification easier to understand and apply. The amendments in this update are effective for the annual reporting period beginning after December 15, 2026, and interim periods within that fiscal year. The Corporation is currently evaluating the impact of such amendments to the consolidated financial statements and related disclosures.

 **(2)&nbsp;&nbsp;&nbsp;&nbsp;Earnings per Common Share**

Basic earnings per common share excludes dilution and is computed by dividing income available to common shareholders by the weighted-average common shares outstanding during the period reduced by unearned ESOP Plan shares and treasury shares. Diluted earnings per common share takes into account the potential dilution computed pursuant to the treasury stock method that could occur if stock options were exercised and converted into common stock, and if restricted stock awards were vested. The effects of stock options are excluded from the computation of diluted earnings per share in periods in which the effect would be anti-dilutive.

---

| | | |
|:---|:---|:---|
| | **Three months ended<br>March 31,** | **Three months ended<br>March 31,** |
| *(dollars in thousands, except per share data)* | **2026** | **2025** |
| **Numerator for earnings per share:** |  |  |
| Net income available to common stockholders | $2006 | $2399 |
| **Denominators for earnings per share:** |  |  |
| Weighted average shares outstanding | 11915 | 11336 |
| Average unearned ESOP shares | (104) | (131) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic weighted averages shares outstanding | 11811 | 11205 |
| Dilutive effects of assumed exercises of stock options | 342 | 241 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted weighted averages shares outstanding | 12153 | 11446 |
| Basic earnings per share | $0.17 | $0.21 |
| Diluted earnings per share | $0.17 | $0.21 |
| Antidilutive shares excluded from computation of average dilutive earnings per share | 78 | 364 |

---

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

**(3)&nbsp;&nbsp;&nbsp;&nbsp;Securities**

The following tables present the amortized cost, allowance for credit losses, and fair value of securities at the dates indicated:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** |
| *(dollars in thousands)* | **Amortized cost** | **Gross unrealized gains** | **Gross unrealized losses** | **Allowance for credit losses** | **Fair value** | **# of Securities in unrealized loss position** |
| **Securities available-for-sale:** |  |  |  |  |  |  |
| U.S. asset backed securities | $25486 | $34 | $(159) | $— | $25361 | 14 |
| U.S. government agency MBS | 22045 | 100 | (329) |  | 21816 | 9 |
| U.S. government agency CMO | 70862 | 232 | (1852) |  | 69242 | 46 |
| State and municipal securities | 43092 | 98 | (3554) |  | 39636 | 32 |
| U.S. Treasuries | 17039 |  | (846) |  | 16193 | 16 |
| Non-U.S. government agency CMO | 7894 | 18 | (225) |  | 7687 | 8 |
| Corporate bonds | 16001 | 325 | (249) |  | 16077 | 10 |
| &nbsp;&nbsp;&nbsp;Total securities available-for-sale | $202419 | $807 | $(7214) | $— | $196012 | 135 |
|  | **Amortized cost** | **Gross unrecognized gains** | **Gross unrecognized losses** | **Allowance for credit losses** | **Fair value** | **# of Securities in unrecognized loss position** |
| **Securities held to maturity:** |  |  |  |  |  |  |
| State and municipal securities | $32494 | $6 | $(2586) | $— | $29914 | 19 |
| &nbsp;&nbsp;&nbsp;Total securities held-to-maturity | $32494 | $6 | $(2586) | $— | $29914 | 19 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
| *(dollars in thousands)* | **Amortized cost** | **Gross unrealized gains** | **Gross unrealized losses** | **Allowance for credit losses** | **Fair value** | **# of Securities in unrealized loss position** |
| **Securities available-for-sale:** |  |  |  |  |  |  |
| U.S. asset backed securities | $26385 | $51 | $(219) | $— | $26217 | 13 |
| U.S. government agency MBS | 22396 | 223 | (268) |  | 22351 | 6 |
| U.S. government agency CMO | 67216 | 441 | (1526) |  | 66131 | 38 |
| State and municipal securities | 43282 | 151 | (3401) |  | 40032 | 31 |
| U.S. Treasuries | 17039 |  | (833) |  | 16206 | 16 |
| Non-U.S. government agency CMO | 8786 | 27 | (207) |  | 8606 | 9 |
| Corporate bonds | 14023 | 266 | (375) |  | 13914 | 11 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total securities available-for-sale | $199127 | $1159 | $(6829) | $— | $193457 | 124 |
| *(dollars in thousands)* | **Amortized cost** | **Gross unrecognized gains** | **Gross unrecognized losses** | **Allowance for credit losses** | **Fair value** | **# of Securities in unrecognized loss position** |
| **Securities held to maturity:** |  |  |  |  |  |  |
| State and municipal securities | $32544 | $22 | $(2414) | $— | $30152 | 19 |
| Total securities held-to-maturity | $32544 | $22 | $(2414) | $— | $30152 | 19 |

---

Although the Corporation's investment portfolio overall is in a net unrealized loss position at March 31, 2026, the temporary impairment in the above noted securities is primarily the result of changes in market interest rates subsequent to purchase and it is more likely than not that the Corporation will not be required to sell these securities prior to recovery to satisfy liquidity needs, and therefore, no securities warranted an ACL.

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

The following table shows the Corporation's investment gross unrealized losses and fair value aggregated by investment category and length of time that individual securities have been in continuous unrealized loss position at the dates indicated:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** |
| | **Less than 12 Months** | **Less than 12 Months** | **12 Months or more** | **12 Months or more** | **Total** | **Total** |
| *(dollars in thousands)* | **Fair<br>value** | **Unrealized losses** | **Fair<br>value** | **Unrealized losses** | **Fair<br>value** | **Unrealized losses** |
| **Securities available-for-sale:** |  |  |  |  |  |  |
| U.S. asset backed securities | $8816 | $(36) | $9496 | $(123) | $18312 | $(159) |
| U.S. government agency MBS | 9739 | (111) | 2518 | (218) | 12257 | (329) |
| U.S. government agency CMO | 34459 | (501) | 15914 | (1351) | 50373 | (1852) |
| State and municipal securities | 1193 | (3) | 34874 | (3551) | 36067 | (3554) |
| U.S. Treasuries |  |  | 16193 | (846) | 16193 | (846) |
| Non-U.S. government agency CMO | 589 | (3) | 4411 | (222) | 5000 | (225) |
| Corporate bonds | 2989 | (11) | 3962 | (238) | 6951 | (249) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total securities available-for-sale | $57785 | $(665) | $87368 | $(6549) | $145153 | $(7214) |
|  | **Less than 12 Months** | **Less than 12 Months** | **12 Months or more** | **12 Months or more** | **Total** | **Total** |
| *(dollars in thousands)* | **Fair<br>value** | **Unrecognized<br>losses** | **Fair<br>value** | **Unrecognized<br>losses** | **Fair<br>value** | **Unrecognized<br>losses** |
| **Securities held-to-maturity:** |  |  |  |  |  |  |
| State and municipal securities | $2084 | $(42) | $25607 | $(2544) | $27691 | $(2586) |
| Total securities held-to-maturity | $2084 | $(42) | $25607 | $(2544) | $27691 | $(2586) |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
| | **Less than 12 Months** | **Less than 12 Months** | **12 Months or more** | **12 Months or more** | **Total** | **Total** |
| *(dollars in thousands)* | **Fair value** | **Unrealized losses** | **Fair value** | **Unrealized losses** | **Fair value** | **Unrealized losses** |
| **Securities available-for-sale:** |  |  |  |  |  |  |
| U.S. asset backed securities | $6504 | $(39) | $11285 | $(180) | $17789 | $(219) |
| U.S. government agency MBS | 3881 | (38) | 3945 | (230) | 7826 | (268) |
| U.S. government agency CMO | 20511 | (178) | 17074 | (1348) | 37585 | (1526) |
| State and municipal securities |  |  | 35212 | (3401) | 35212 | (3401) |
| U.S. Treasuries |  |  | 16206 | (833) | 16206 | (833) |
| Non-U.S. government agency CMO | 456 |  | 5235 | (207) | 5691 | (207) |
| Corporate bonds | 1476 | (26) | 4879 | (349) | 6355 | (375) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total securities available-for-sale | $32828 | $(281) | $93836 | $(6548) | $126664 | $(6829) |
|  | **Less than 12 Months** | **Less than 12 Months** | **12 Months or more** | **12 Months or more** | **Total** | **Total** |
| *(dollars in thousands)* | **Fair<br>value** | **Unrecognized<br>losses** | **Fair<br>value** | **Unrecognized<br>losses** | **Fair<br>value** | **Unrecognized<br>losses** |
| **Securities held-to-maturity:** |  |  |  |  |  |  |
| State and municipal securities | $2087 | $(69) | $25842 | $(2345) | $27929 | $(2414) |
| &nbsp;&nbsp;&nbsp;Total securities held-to-maturity | $2087 | $(69) | $25842 | $(2345) | $27929 | $(2414) |

---

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

As of March 31, 2026, substantially all of the Corporation's available-for-sale investment securities were mortgage-backed securities or collateral mortgage obligations which were issued or guaranteed by U.S. government-sponsored entities and agencies. As of March 31, 2026 and December 31, 2025, there were no holdings of securities of any one issuer, other than the U.S. government and its agencies, in an amount greater than 10% of stockholders' equity.

The amortized cost and carrying value of securities are shown below by contractual maturities at the dates indicated. Actual maturities may differ from contractual maturities as issuers may have the right to call or repay obligations with or without call or prepayment penalties.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** |
| | **Available-for-sale** | **Available-for-sale** | **Held-to-maturity** | **Held-to-maturity** |
| *(dollars in thousands)* | **Amortized cost** | **Fair value** | **Amortized cost** | **Fair value** |
| Due in one year or less | $— | $— | $— | $— |
| Due after one year through five years | 101618 | 97267 | 32305 | 29725 |
| Due after five years through ten years |  |  |  |  |
| Due after ten years |  |  | 189 | 189 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subtotal | 101618 | 97267 | 32494 | 29914 |
| Mortgage-related securities | 100801 | 98745 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $202419 | $196012 | $32494 | $29914 |

---

There were no sales of investment securities available for sale for the three months ended March 31, 2026, or March 31, 2025.

***ACL on Securities AFS and HTM***

We use credit ratings quarterly and the most recent financial information of securities' issuers annually to help evaluate the credit quality of our securities AFS and HTM portfolios on a quarterly basis. The securities portfolio consists primarily of U.S. government treasuries and U.S. government agency asset backed securities which have no probability of default. The remaining portfolio consists of highly rated municipal bonds, non-agency CMO, and corporate bonds that have a low probability of default.

For the three months ended March 31, 2026 and 2025, we had no significant ACL or provision expense and no charge-offs or recoveries on AFS or HTM securities.

***Pledged Securities***

As of March 31, 2026 and December 31, 2025, securities having a carrying value of $72.9 million and $69.5 million, respectively, were specifically pledged as collateral for public funds, the FRB discount window program, FHLB borrowings and other purposes. The FHLB has a blanket lien on non-pledged, mortgage-related loans and securities as part of the Corporation's borrowing agreement

.

**(4)&nbsp;&nbsp;&nbsp;&nbsp;Loans and Other Finance Receivables**

The following table presents loans and other finance receivables detailed by category at the dates indicated:

---

| | | |
|:---|:---|:---|
| *(dollars in thousands)* | **March 31,<br>2026** | **December 31,<br>2025** |
| Real estate loans: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commercial mortgage | $870544 | $879440 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Home equity lines and loans | 109795 | 107002 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Residential mortgage | 235067 | 236135 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Construction | 343376 | 330543 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total real estate loans | 1558782 | 1553120 |
| Commercial, industrial & other finance receivables | 444395 | 428981 |
| Small business loans | 134468 | 139765 |
| Consumer | 303 | 329 |
| Leases, net | 40837 | 45489 |
| Loans and other finance receivables | $2178785 | $2167684 |
| **Balances included in loans and other finance receivables** |  |  |
| Residential mortgage real estate loans accounted under fair value option, at fair value | $14090 | $14396 |
| Residential mortgage real estate loans accounted under fair value option, at amortized cost | 15925 | 16169 |
| Unearned lease income included in leases, net | (4702) | (4980) |
| Unamortized net deferred loan origination costs, not included in loans above | 2790 | 2916 |

---

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

***Fair Value Option for Residential Mortgage Real Estate Loans***

Residential mortgage real estate loans that were originated by the Corporation and intended for sale in the secondary market to permanent investors, but were either repurchased or unsalable due to defect, and that the Corporation has the ability and intent to hold for the foreseeable future or until maturity or payoff are carried at fair value pursuant to the Corporation's election of the fair value option for these loans. The remaining loans, net of fees and costs are stated at their outstanding unpaid principal balances, net of deferred fees or costs, since the original intent for these loans was to hold them until payoff or maturity.

***Past Due and Nonaccrual Loans***

The following tables present an aging of the Corporation's loans at the dates indicated:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** |
| *(dollars in thousands)* | **30-59 days past due** | **60-89 days past due** | **Total past due** | **Current** | **Total accruing** | **Nonaccrual** | **Total loans and other finance receivables** | **% Delinquent** |
| Commercial mortgage | $7270 | $13 | $7283 | $856513 | $863796 | $6748 | $870544 | 1.61% |
| Home equity lines and loans | 332 |  | 332 | 107240 | 107572 | 2223 | 109795 | 2.33 |
| Residential mortgage <sup>(1)</sup> | 1890 | 189 | 2079 | 223638 | 225717 | 9350 | 235067 | 4.86 |
| Construction |  |  |  | 335688 | 335688 | 7688 | 343376 | 2.24 |
| Commercial, industrial & other finance receivables | 1100 |  | 1100 | 436116 | 437216 | 7179 | 444395 | 1.86 |
| Small business loans <sup>(2)</sup> | 2269 |  | 2269 | 108288 | 110557 | 23911 | 134468 | 19.47 |
| Consumer |  |  |  | 303 | 303 |  | 303 |  |
| Leases, net | 409 | 353 | 762 | 38515 | 39277 | 1560 | 40837 | 5.69% |
| Total | $13270 | $555 | $13825 | $2106301 | $2120126 | $58659 | $2178785 | 3.33% |

---

(1) Includes $14.1 million of loans at fair value of which $13.2 million are current, $352 thousand are 30-89 days past due and $497 thousand are nonaccrual.

(2) Includes $12.9 million of loans within nonaccrual category that are guaranteed by the SBA.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
| *(dollars in thousands)* | **30-59 days past due** | **60-89 days past due** | **Total past due** | **Current** | **Total accruing** | **Nonaccrual** | **Total loans and other finance receivables** | **% Delinquent** |
| Commercial mortgage | $1059 | $328 | $1387 | $875581 | $876968 | $2472 | $879440 | 0.44% |
| Home equity lines and loans | 513 |  | 513 | 104466 | 104979 | 2023 | 107002 | 2.37 |
| Residential mortgage <sup>(1)</sup> | 1843 | 621 | 2464 | 223286 | 225750 | 10385 | 236135 | 5.44 |
| Construction |  |  |  | 323893 | 323893 | 6650 | 330543 | 2.01 |
| Commercial, industrial & other finance receivables | 1099 |  | 1099 | 421112 | 422211 | 6770 | 428981 | 1.83 |
| Small business loans <sup>(2)</sup> | 739 |  | 739 | 114245 | 114984 | 24781 | 139765 | 18.26 |
| Consumer |  |  |  | 329 | 329 |  | 329 |  |
| Leases, net | 699 | 249 | 948 | 42562 | 43510 | 1979 | 45489 | 6.43 |
| Total | $5952 | $1198 | $7150 | $2105474 | $2112624 | $55060 | $2167684 | 2.87% |

---

(1) Includes $14.4 million of loans at fair value of which $13.3 million are current, $604 thousand are 30-89 days past due and $510 thousand are nonaccrual.

(2) Includes $13.2 million of loans within nonaccrual category that are guaranteed by the SBA.

There were no loans or other finance receivables in the tables above as of March 31, 2026 or December 31, 2025, that were 90+days past due and still accruing interest.

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

***Foreclosed and Repossessed Assets***

At March 31, 2026 and December 31, 2025, there were six and 11 consumer mortgage loans, respectively, secured by residential real estate properties (included in loans, net of fees and costs on the Consolidated Balance Sheets) totaling $1.6 million and $3.1 million, respectively, for which formal foreclosure proceedings were in process.

***Risks and Uncertainties***

We have no particular credit concentration. Our commercial loans have been proactively managed in an effort to achieve a balanced portfolio with no unusual exposure to one industry. Additionally, most of our lending activity occurs within our primary market areas which are concentrated in southeastern Pennsylvania, Delaware, and Maryland as well as other contiguous markets and represents a geographic concentration. Additionally, our loan portfolio is concentrated in commercial loans. Commercial loans are generally viewed as having more inherent risk of default than residential real estate loans or other consumer loans. Also, the commercial loan balance per borrower is typically larger than that for residential real estate loans and consumer loans, implying higher potential losses on an individual loan basis.

***Past Due and Nonaccrual Status***

The following table presents the amortized costs basis of loans on nonaccrual status, net of fees and costs as of March 31, 2026 and December 31, 2025. As of these dates there were no loans 90 days or more past due and still accruing.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
| *(dollars in thousands)* | **Nonaccrual without ACL** | **Nonaccrual with ACL** | **Total nonaccrual** | **Nonaccrual without ACL** | **Nonaccrual with ACL** | **Total nonaccrual** |
| Commercial mortgage | $6748 | $— | $6748 | $2472 | $— | $2472 |
| Home equity lines and loans | 2025 | 198 | 2223 | 2023 |  | 2023 |
| Residential mortgage | 7490 | 1860 | 9350 | 9020 | 1365 | 10385 |
| Construction | 3669 | 4019 | 7688 | 1889 | 4761 | 6650 |
| Commercial, industrial & other finance receivables | 6080 | 1099 | 7179 | 6770 |  | 6770 |
| Small business loans <sup>(1)</sup> | 19678 | 4233 | 23911 | 18050 | 6731 | 24781 |
| Leases, net |  | 1560 | 1560 |  | 1979 | 1979 |
| Total | $45690 | $12969 | $58659 | $40224 | $14836 | $55060 |

---

(1) Included in non-performing small business loans as of March 31, 2026 and December 31, 2025, are $12.9 million and $13.2 million in SBA guarantees.

**Collateral-dependent Loans**

The following table presents the amortized cost basis of non-accruing collateral-dependent loans and other finance receivables by class as of March 31, 2026 and December 31, 2025 under the current expected credit loss model:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
| *(dollars in thousands)* | **Real estate** | **Equipment and other** | **Total** | **Real estate** | **Equipment and other** | **Total** |
| Commercial mortgage | $6748 | $— | $6748 | $2472 | $— | $2472 |
| Home equity lines and loans | 2223 |  | 2223 | 2023 |  | 2023 |
| Residential mortgage | 9350 |  | 9350 | 10385 |  | 10385 |
| Construction | 7688 |  | 7688 | 6650 |  | 6650 |
| Commercial, industrial & other finance receivables | 849 | 6330 | 7179 | 1372 | 5398 | 6770 |
| Small business loans | 19874 | 4037 | 23911 | 19287 | 5494 | 24781 |
| Total | $46732 | $10367 | $57099 | $42189 | $10892 | $53081 |

---

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

**(5)&nbsp;&nbsp;&nbsp;&nbsp;Allowance for Credit Losses**

The ACL is maintained at a level considered adequate to provide for estimated expected credit losses within the loan portfolio over the contractual life of an instrument that considers our historical loss experience, current conditions and forecasts of future economic conditions as of the balance sheet date. Management's periodic evaluation of the adequacy of the ACL is based on known and inherent risks in the portfolio, adverse situations that may affect the borrower's ability to repay, the estimated value of any underlying collateral, composition of the loan portfolio, current economic conditions and other relevant factors. This evaluation is subjective as it requires material estimates that may be susceptible to significant revisions as more information becomes available.

***Roll-Forward of ACL by Portfolio Segment***

The following tables provide the activity of our allowance for credit losses for the three months ended March 31, 2026 and March 31, 2025 under the CECL model in accordance with ASC 326:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** |
| *(dollars in thousands)* | **Beginning Balance** | **Charge-offs** | **Recoveries** | **Provision (recovery of provision) for credit losses** | **Ending balance** |
| Commercial mortgage | $3676 | $(3867) | $— | $3740 | $3549 |
| Home equity lines and loans | 1162 |  | 1 | 109 | 1272 |
| Residential mortgage | 926 |  |  | 137 | 1063 |
| Construction | 2067 |  |  | 163 | 2230 |
| Commercial, industrial & other finance receivables | 2982 | (1005) | 60 | 2032 | 4069 |
| Small business loans | 9321 | (2549) | 62 | 894 | 7728 |
| Consumer |  |  | 1 | (1) |  |
| Leases | 1439 | (745) | 283 | 364 | 1341 |
| Total | $21573 | $(8166) | $407 | $7438 | $21252 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** |
| *(dollars in thousands)* | **Beginning Balance** | **Charge-offs** | **Recoveries** | **Provision (recovery of provision) for credit losses** | **Ending balance** |
| Commercial mortgage | $3469 | $— | $— | $(87) | $3382 |
| Home equity lines and loans | 1147 |  | 2 | 16 | 1165 |
| Residential mortgage | 1021 |  |  | 6 | 1027 |
| Construction | 923 | (738) |  | 1456 | 1641 |
| Commercial, industrial & other finance receivables | 3098 | (1430) | 17 | 1080 | 2765 |
| Small business loans | 6304 | (277) | 29 | 2555 | 8611 |
| Consumer |  |  | 1 | (1) |  |
| Leases | 2476 | (553) | 126 | 187 | 2236 |
| Total | $18438 | $(2998) | $175 | $5212 | $20827 |

---

***Reconciliation of Provision for Credit Losses***

The following table provides a reconciliation of the provision for credit losses on the consolidated statements of income between the funded and unfunded components at the dates indicated:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended <br>March 31,** | **Three Months Ended <br>March 31,** |
| *(dollars in thousands)* | **2026** | **2025** |
| Provision for credit losses - funded loans | $7438 | $5212 |
| Provision for credit losses - unfunded loans | 55 |  |
| Total provision for credit losses | $7493 | $5212 |

---

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

***Allowance Allocated by Portfolio Segment***

The following tables detail the allocation of the ACL and the carrying value for loans and other finance receivables by portfolio segment based on the methodology used to evaluate the loans and other finance receivables at the dates indicated:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** |
| | **Allowance for credit losses** | **Allowance for credit losses** | **Allowance for credit losses** | **Carrying value of loans and leases** | **Carrying value of loans and leases** | **Carrying value of loans and leases** |
| *(dollars in thousands)* | **Individually evaluated** | **Collectively evaluated** | **Total** | **Individually evaluated** | **Collectively evaluated** | **Total** |
| Commercial mortgage | $— | $3549 | $3549 | $6748 | $863796 | $870544 |
| Home equity lines and loans | 57 | 1215 | 1272 | 2223 | 107572 | 109795 |
| Residential mortgage <sup>(1)</sup> | 177 | 886 | 1063 | 8853 | 212124 | 220977 |
| Construction | 307 | 1923 | 2230 | 7688 | 335688 | 343376 |
| Commercial, industrial & other finance receivables | 977 | 3092 | 4069 | 7179 | 437216 | 444395 |
| Small business loans | 1308 | 6420 | 7728 | 23911 | 110557 | 134468 |
| Consumer |  |  |  |  | 303 | 303 |
| Leases, net |  | 1341 | 1341 |  | 40837 | 40837 |
| Total <sup>(2)</sup> | $2826 | $18426 | $21252 | $56602 | $2108093 | $2164695 |

---

(1) Excludes $14.1 million of loans at fair value.

(2) Excludes deferred fees.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
| | **Allowance for credit losses** | **Allowance for credit losses** | **Allowance for credit losses** | **Carrying value of loans and leases** | **Carrying value of loans and leases** | **Carrying value of loans and leases** |
| *(dollars in thousands)* | **Individually evaluated** | **Collectively evaluated** | **Total** | **Individually evaluated** | **Collectively evaluated** | **Total** |
| Commercial mortgage | $— | $3676 | $3676 | $2472 | $876968 | $879440 |
| Home equity lines and loans |  | 1162 | 1162 | 2023 | 104979 | 107002 |
| Residential mortgage <sup>(1)</sup> | 122 | 804 | 926 | 9875 | 211864 | 221739 |
| Construction | 331 | 1736 | 2067 | 6650 | 323893 | 330543 |
| Commercial, industrial & other finance receivables |  | 2982 | 2982 | 6770 | 422211 | 428981 |
| Small business loans | 2986 | 6335 | 9321 | 24781 | 114984 | 139765 |
| Consumer |  |  |  |  | 329 | 329 |
| Leases, net |  | 1439 | 1439 |  | 45489 | 45489 |
| Total <sup>(2)</sup> | $3439 | $18134 | $21573 | $52571 | $2100717 | $2153288 |

---

(1) Excludes $14.4 million of loans at fair value.

(2) Excludes deferred fees.

***Credit Quality Indicators***

As part of the process of determining the ACL to the different segments of the loan and lease portfolio, Management considers certain credit quality indicators. For the commercial mortgage, construction and commercial and industrial loan segments, periodic reviews of the individual loans are performed by Management. The results of these reviews are reflected in the risk grade assigned to each loan. These internally assigned grades are as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Pass** – Considered to be satisfactory with no indications of deterioration.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Special mention –** Loans classified as special mention have a potential weakness that deserves Management's close attention. If left uncorrected, these potential weaknesses may result in deterioration of the repayment prospects for the loan or of the institution's credit position at some future date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Substandard –** Loans classified as substandard are inadequately protected by the current net worth and payment capacity of the obligor or of the collateral pledged, if any. Substandard loans have a well-defined weakness or weaknesses that jeopardize the liquidation of the debt. They are characterized by the distinct possibility that the institution will sustain some loss if the deficiencies are not corrected.

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Doubtful –** Loans classified as doubtful have all the weaknesses inherent in those classified as substandard, with the added characteristic that the weaknesses make collection or liquidation in full, on the basis of currently existing facts, conditions, and values, highly questionable and improbable. Loan balances classified as doubtful have been reduced by partial charge-offs and are carried at their net realizable values.

The following tables detail the carrying value of loans and other finance receivables by portfolio segment based on year of origination and the credit quality indicators used to determine the allowance for credit losses at the dates indicated:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **Revolving Loans Converted to Term Loans** | **Revolving Loans** | **Total** |
| | **Term Loans and Other Finance Receivables** | **Term Loans and Other Finance Receivables** | **Term Loans and Other Finance Receivables** | **Term Loans and Other Finance Receivables** | **Term Loans and Other Finance Receivables** | **Term Loans and Other Finance Receivables** | **Revolving Loans Converted to Term Loans** | **Revolving Loans** | **Total** |
| *(dollars in thousands)* | **2026** | **2025** | **2024** | **2023** | **2022** | **Prior** | **Revolving Loans Converted to Term Loans** | **Revolving Loans** | **Total** |
| **<u>Commercial mortgage</u>** | **<u>Commercial mortgage</u>** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pass/Watch | $15213 | $110152 | $127157 | $99056 | $160664 | $324893 | $— | $— | $837135 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  |  |  | 10782 | 1458 | 2990 |  |  | 15230 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Substandard |  | 5022 | 1339 | 1008 | 4163 | 6647 |  |  | 18179 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $15213 | $115174 | $128496 | $110846 | $166285 | $334530 | $— | $— | $870544 |
| Year-to-date gross charge-offs | $— | $— | $— | $— | $(3867) | $— | $— | $— | $(3867) |
| **<u>Construction</u>** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pass/Watch | $17502 | $135491 | $104605 | $19908 | $3246 | $11538 | $— | $32634 | $324924 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Substandard | 239 | 1430 | 211 | 1185 | 10887 | 1864 |  | 2636 | 18452 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $17741 | $136921 | $104816 | $21093 | $14133 | $13402 | $— | $35270 | $343376 |
| Year-to-date gross charge-offs | $— | $— | $— | $— | $— | $— | $— | $— | $— |
| **<u>Commercial, industrial & other finance receivables</u>** | **<u>Commercial, industrial & other finance receivables</u>** | **<u>Commercial, industrial & other finance receivables</u>** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pass/Watch | $34672 | $68269 | $62471 | $13928 | $16796 | $30030 | $— | $189752 | $415918 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  |  |  |  | 128 | 3775 |  | 8444 | 12347 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Substandard |  | 350 |  | 850 |  | 6286 |  | 8644 | 16130 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $34672 | $68619 | $62471 | $14778 | $16924 | $40091 | $— | $206840 | $444395 |
| Year-to-date gross charge-offs | $— | $(766) | $(90) | $— | $— | $(125) | $— | $(24) | $(1005) |
| **<u>Small business loans</u>** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pass/Watch | $10286 | $22537 | $15396 | $13879 | $15730 | $17698 | $— | $8840 | $104366 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  | 513 | 109 | 1861 |  | 170 |  | 449 | 3102 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Substandard |  | 3238 | 1537 | 4814 | 1015 | 12974 |  | 3422 | 27000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $10286 | $26288 | $17042 | $20554 | $16745 | $30842 | $— | $12711 | $134468 |
| Year-to-date gross charge-offs | $— | $(605) | $(994) | $(168) | $(171) | $(181) | $— | $(430) | $(2549) |
| **<u>Total by risk rating</u>** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pass/Watch | $77673 | $336449 | $309629 | $146771 | $196436 | $384159 | $— | $231226 | $1682343 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  | 513 | 109 | 12643 | 1586 | 6935 |  | 8893 | 30679 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Substandard | 239 | 10040 | 3087 | 7857 | 16065 | 27771 |  | 14702 | 79761 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $77912 | $347002 | $312825 | $167271 | $214087 | $418865 | $— | $254821 | $1792783 |
| Total year-to-date gross charge-offs | $— | $(1371) | $(1084) | $(168) | $(4038) | $(306) | $— | $(454) | $(7421) |

---

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **Revolving Loans Converted to Term Loans** | **Revolving Loans** | **Total** |
| | **Term Loans and Other Finance Receivables** | **Term Loans and Other Finance Receivables** | **Term Loans and Other Finance Receivables** | **Term Loans and Other Finance Receivables** | **Term Loans and Other Finance Receivables** | **Term Loans and Other Finance Receivables** | **Revolving Loans Converted to Term Loans** | **Revolving Loans** | **Total** |
| *(dollars in thousands)* | **2025** | **2024** | **2023** | **2022** | **2021** | **Prior** | **Revolving Loans Converted to Term Loans** | **Revolving Loans** | **Total** |
| **<u>Commercial mortgage</u>** | **<u>Commercial mortgage</u>** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pass/Watch | $116630 | $116852 | $102516 | $162329 | $127627 | $227348 | $— | $— | $853302 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  |  | 4487 | 1474 |  | 4159 |  |  | 10120 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Substandard |  |  | 1029 | 8074 |  | 6915 |  |  | 16018 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $116630 | $116852 | $108032 | $171877 | $127627 | $238422 | $— | $— | $879440 |
| Year-to-date gross charge-offs | $— | $— | $— | $— | $— | $— | $— | $— | $— |
| **<u>Construction</u>** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pass/Watch | $117778 | $118733 | $19858 | $9212 | $3373 | $8263 | $— | $29906 | $307123 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  |  | 6245 |  |  |  |  |  | 6245 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Substandard | 1430 | 211 | 1185 | 9096 | 1826 | 492 |  | 2935 | 17175 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $119208 | $118944 | $27288 | $18308 | $5199 | $8755 | $— | $32841 | $330543 |
| Year-to-date gross charge-offs | $— | $— | $— | $— | $— | $— | $— | $(738) | $(738) |
| **<u>Commercial, industrial & other finance receivables</u>** | **<u>Commercial, industrial & other finance receivables</u>** | **<u>Commercial, industrial & other finance receivables</u>** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pass/Watch | $84183 | $62904 | $16119 | $17270 | $9224 | $21836 | $— | $193356 | $404892 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  |  |  | 145 | 3857 |  |  | 4608 | 8610 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Substandard |  |  | 850 |  | 523 | 5360 |  | 8746 | 15479 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $84183 | $62904 | $16969 | $17415 | $13604 | $27196 | $— | $206710 | $428981 |
| Year-to-date gross charge-offs | $(739) | $(1487) | $(160) | $(23) | $(1089) | $— | $— | $(1290) | $(4788) |
| **<u>Small business loans</u>** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pass/Watch | $29760 | $17403 | $17955 | $16903 | $9448 | $8935 | $— | $10713 | $111117 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  | 477 | 134 |  |  |  |  | 140 | 751 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Substandard | 2567 | 2127 | 3893 | 874 | 10523 | 4002 |  | 3911 | 27897 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $32327 | $20007 | $21982 | $17777 | $19971 | $12937 | $— | $14764 | $139765 |
| Year-to-date gross charge-offs | $(1211) | $(433) | $(550) | $(233) | $(692) | $(1057) | $— | $(813) | $(4989) |
| **<u>Total by risk rating</u>** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pass/Watch | $348351 | $315892 | $156448 | $205714 | $149672 | $266382 | $— | $233975 | $1676434 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  | 477 | 10866 | 1619 | 3857 | 4159 |  | 4748 | 25726 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Substandard | 3997 | 2338 | 6957 | 18044 | 12872 | 16769 |  | 15592 | 76569 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $352348 | $318707 | $174271 | $225377 | $166401 | $287310 | $— | $254315 | $1778729 |
| Total year-to-date gross charge-offs | $(1950) | $(1920) | $(710) | $(256) | $(1781) | $(1057) | $— | $(2841) | $(10515) |

---

The Corporation had no loans with a risk rating of Doubtful included within recorded investment in loans and leases held for investment at March 31, 2026 and December 31, 2025.

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

In addition to credit quality indicators as shown in the above tables, allowance allocations for home equity lines and loans, residential mortgages, consumer loans and leases are also applied based on their year of origination and performance status at the dates indicated:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **Revolving Loans** | **Total** |
| | **Term Loans and Other Finance Receivables** | **Term Loans and Other Finance Receivables** | **Term Loans and Other Finance Receivables** | **Term Loans and Other Finance Receivables** | **Term Loans and Other Finance Receivables** | **Term Loans and Other Finance Receivables** | **Revolving Loans** | **Total** |
| *(dollars in thousands)* | **2026** | **2025** | **2024** | **2023** | **2022** | **Prior** | **Revolving Loans** | **Total** |
| **<u>Home equity lines and loans</u>** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Performing | $— | $1094 | $654 | $194 | $473 | $3119 | $102038 | $107572 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonperforming |  |  |  |  |  | 433 | 1790 | 2223 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $— | $1094 | $654 | $194 | $473 | $3552 | $103828 | $109795 |
| Year-to-date gross charge-offs | $— | $— | $— | $— | $— | $— | $— | $— |
| **<u>Residential mortgage</u>** <sup>(1)</sup> |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Performing | $3725 | $25616 | $7663 | $24072 | $122514 | $28144 | $390 | $212124 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonperforming |  |  | 722 | 669 | 2272 | 5190 |  | 8853 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $3725 | $25616 | $8385 | $24741 | $124786 | $33334 | $390 | $220977 |
| Year-to-date gross charge-offs | $— | $— | $— | $— | $— | $— | $— | $— |
| **<u>Consumer</u>** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Performing | $— | $— | $— | $20 | $9 | $186 | $88 | $303 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonperforming |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $— | $— | $— | $20 | $9 | $186 | $88 | $303 |
| Year-to-date gross charge-offs | $— | $— | $— | $— | $— | $— | $— | $— |
| **<u>Leases, net</u>** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Performing | $3400 | $5792 | $379 | $8595 | $16253 | $4910 | $— | $39329 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonperforming |  |  |  | 561 | 819 | 128 |  | 1508 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $3400 | $5792 | $379 | $9156 | $17072 | $5038 | $— | $40837 |
| Year-to-date gross charge-offs | $— | $(94) | $— | $(154) | $(238) | $(259) | $— | $(745) |
| **<u>Total by Payment Performance</u>** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Performing | $7125 | $32502 | $8696 | $32881 | $139249 | $36359 | $102516 | $359328 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonperforming |  |  | 722 | 1230 | 3091 | 5751 | 1790 | 12584 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $7125 | $32502 | $9418 | $34111 | $142340 | $42110 | $104306 | $371912 |
| Total year-to-date gross charge-offs | $— | $(94) | $— | $(154) | $(238) | $(259) | $— | $(745) |
| (1) Excludes $14.1 million of loans at fair value. | (1) Excludes $14.1 million of loans at fair value. |  |  |  |  |  |  |  |

---

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **Revolving Loans** | **Total** |
| | **Term Loans and Other Finance Receivables** | **Term Loans and Other Finance Receivables** | **Term Loans and Other Finance Receivables** | **Term Loans and Other Finance Receivables** | **Term Loans and Other Finance Receivables** | **Term Loans and Other Finance Receivables** | **Revolving Loans** | **Total** |
| *(dollars in thousands)* | **2025** | **2024** | **2023** | **2022** | **2021** | **Prior** | **Revolving Loans** | **Total** |
| **<u>Home equity lines and loans</u>** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Performing | $1103 | $658 | $196 | $534 | $207 | $3102 | $99179 | $104979 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonperforming |  |  |  |  | 91 | 342 | 1590 | 2023 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $1103 | $658 | $196 | $534 | $298 | $3444 | $100769 | $107002 |
| Year-to-date gross charge-offs | $— | $— | $— | $— | $— | $— | $— | $— |
| **<u>Residential mortgage</u>** <sup>(1)</sup> |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Performing | $25957 | $8080 | $26278 | $122566 | $15775 | $13208 | $— | $211864 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonperforming |  | 437 | 672 | 3398 | 737 | 4631 |  | 9875 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $25957 | $8517 | $26950 | $125964 | $16512 | $17839 | $— | $221739 |
| Year-to-date gross charge-offs | $— | $— | $— | $— | $— | $— | $— | $— |
| **<u>Consumer</u>** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Performing | $— | $5 | $22 | $12 | $— | $220 | $70 | $329 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonperforming |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $— | $5 | $22 | $12 | $— | $220 | $70 | $329 |
| Year-to-date gross charge-offs | $— | $— | $— | $— | $— | $— | $(11) | $(11) |
| **<u>Leases, net</u>** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Performing | $6232 | $482 | $10149 | $19369 | $6561 | $717 | $— | $43510 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonperforming |  |  | 518 | 1099 | 342 | 20 |  | 1979 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $6232 | $482 | $10667 | $20468 | $6903 | $737 | $— | $45489 |
| Year-to-date gross charge-offs | $— | $— | $(90) | $(1472) | $(756) | $(40) | $— | $(2358) |
| **<u>Total by Payment Performance</u>** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Performing | $33292 | $9225 | $36645 | $142481 | $22543 | $17247 | $99249 | $360682 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonperforming |  | 437 | 1190 | 4497 | 1170 | 4993 | 1590 | 13877 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $33292 | $9662 | $37835 | $146978 | $23713 | $22240 | $100839 | $374559 |
| Total year-to-date gross charge-offs | $— | $— | $(90) | $(1472) | $(756) | $(40) | $(11) | $(2369) |
| (1) Excludes $14.4 million of fair value loans. | (1) Excludes $14.4 million of fair value loans. |  |  |  |  |  |  |  |

---

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

***Modifications to Borrowers Experiencing Financial Difficulty***

An assessment of whether a borrower is experiencing financial difficulty is made on the date of a modification. Because the effect of most modifications made to borrowers experiencing financial difficulty is already included in the ACL on loans and leases, a change to the allowance for credit losses is generally not recorded upon modification. However, when principal forgiveness is provided, the amortized cost basis of the asset is written off against the ACL on loans and leases. The amount of the principal forgiveness is deemed to be uncollectible; therefore, that portion of the loan is written off, resulting in a reduction of the amortized cost basis and a corresponding adjustment to the allowance for credit losses.

The following presents, by class, information regarding accruing and nonaccrual modifications to borrowers experiencing financial difficulty during the three months ended March 31, 2026 and 2025.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** |
| *(dollars in thousands)* | **Number** | **Amortized Cost Basis** | **% of Total Class of Financing Receivable** | **Related Reserve** | **Number** | **Amortized Cost Basis** | **% of Total Class of Financing Receivable** | **Related Reserve** |
| **Accruing Modifications to Borrowers Experiencing Financial Difficulty:** | **Accruing Modifications to Borrowers Experiencing Financial Difficulty:** | **Accruing Modifications to Borrowers Experiencing Financial Difficulty:** | **Accruing Modifications to Borrowers Experiencing Financial Difficulty:** | **Accruing Modifications to Borrowers Experiencing Financial Difficulty:** | **Accruing Modifications to Borrowers Experiencing Financial Difficulty:** | **Accruing Modifications to Borrowers Experiencing Financial Difficulty:** | **Accruing Modifications to Borrowers Experiencing Financial Difficulty:** | **Accruing Modifications to Borrowers Experiencing Financial Difficulty:** |
| Commercial mortgage | 3 | $4245 | 0.5% | $— | 1 | $959 | 0.1% | $— |
| Construction | 4 | 14265 | 4.2% | 83 | 3 | 2869 | 1.0% |  |
| Commercial, industrial & other finance receivables |  |  | —% |  | 1 | 1095 | 0.3% |  |
| Small business loans | 2 | 1094 | 0.8% | 234 | 3 | 1948 | 1.2% |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 9 | $19604 |  | $317 | 8 | $6871 |  | $— |
| **Nonaccrual Modifications to Borrowers Experiencing Financial Difficulty:** | **Nonaccrual Modifications to Borrowers Experiencing Financial Difficulty:** | **Nonaccrual Modifications to Borrowers Experiencing Financial Difficulty:** | **Nonaccrual Modifications to Borrowers Experiencing Financial Difficulty:** | **Nonaccrual Modifications to Borrowers Experiencing Financial Difficulty:** | **Nonaccrual Modifications to Borrowers Experiencing Financial Difficulty:** | **Nonaccrual Modifications to Borrowers Experiencing Financial Difficulty:** | **Nonaccrual Modifications to Borrowers Experiencing Financial Difficulty:** | **Nonaccrual Modifications to Borrowers Experiencing Financial Difficulty:** |
| Commercial mortgage | 1 | $2943 | 0.3% | $— |  | $— | —% | $— |
| Residential mortgage | 1 | 225 | 0.1% |  |  |  | —% |  |
| Construction | 1 | 1383 | 0.4% | 115 | 1 | 2907 | 1.0% |  |
| Small business loans |  |  | —% |  | 1 | 565 | 0.4% | 434 |
| Leases | 9 | 242 | 0.6% | 6 |  |  | —% |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 12 | $4793 |  | $121 | 2 | $3472 |  | $434 |

---

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

The following presents, by class, information regarding accruing and nonaccrual modifications to borrowers experiencing financial difficulty during the three months ended March 31, 2026 and 2025.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended <br>March 31, 2026** | **Three Months Ended <br>March 31, 2026** | **Three Months Ended <br>March 31, 2025** | **Three Months Ended <br>March 31, 2025** |
| | **Number** | **Financial Effect** | **Number** | **Financial Effect** |
| **Accruing Modifications to Borrowers Experiencing Financial Difficulty:** | **Accruing Modifications to Borrowers Experiencing Financial Difficulty:** | **Accruing Modifications to Borrowers Experiencing Financial Difficulty:** | **Accruing Modifications to Borrowers Experiencing Financial Difficulty:** | **Accruing Modifications to Borrowers Experiencing Financial Difficulty:** |
| Commercial mortgage | 3 | Extend maturity date | 1 | Extend maturity/payment |
| Construction | 4 | Extend maturity date | 3 | Extend maturity date |
| Commercial, industrial & other finance receivables |  |  | 1 | Extend maturity date |
| Small business loans | 2 | Extend maturity date | 3 | Extend maturity date |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 9 |  | 8 |  |
| **Nonaccrual Modifications to Borrowers Experiencing Financial Difficulty:** | **Nonaccrual Modifications to Borrowers Experiencing Financial Difficulty:** | **Nonaccrual Modifications to Borrowers Experiencing Financial Difficulty:** | **Nonaccrual Modifications to Borrowers Experiencing Financial Difficulty:** |  |
| Commercial mortgage | 1 | Interest only payments |  |  |
| Residential mortgage | 1 | Extend maturity date |  |  |
| Construction | 1 | Extend maturity date | 1 | Extend maturity date |
| Small business loans |  |  | 1 | Extend maturity date |
| Leases | 9 | Extend maturity date |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 12 |  | 2 |  |

---

There were 21 and 10 modifications granted to borrowers experiencing financial difficulty during the three months ended March 31, 2026 and March 31, 2025, respectively. There were no loans that had payment defaults during the three months ended March 31, 2026, and 2025, respectively. There were $634 thousand in commitments to lend additional funds to the borrowers experiencing financial difficulty that had modifications during the three months ended March 31, 2026 and $882 thousand in commitments to lend additional funds to such borrowers during the three months ended March 31, 2025.

The increase period over period in assistance provided to borrowers experiencing financial difficulty was seen in leases, construction and commercial mortgage loans. The primary factor for the financial difficulty generally comes from higher interest rates or higher rates for longer periods.

The following presents, by class of loans, the amortized cost and performance status of accruing and nonaccrual modified loans to borrowers experiencing financial difficulty that have been modified in the last 12 months as of March 31, 2026 and 2025.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** |
| | **Current** | **30-59 days past due** | **60-89 days past due** | **90+ days past due and still accruing** | **Nonaccrual loans and leases** | **Total** |
| *(dollars in thousands)* | **Current** | **30-59 days past due** | **60-89 days past due** | **90+ days past due and still accruing** | **Nonaccrual loans and leases** | **Total** |
| Commercial mortgage | $4245 | $— | $— | $— | $4330 | $8574 |
| Residential mortgage | 529 |  |  |  | 597 | 1126 |
| Construction | 14265 |  |  |  | 1383 | 15648 |
| Small business loans | 1402 |  |  |  | 3601 | 5003 |
| Leases |  |  |  |  | 242 | 242 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $20441 | $— | $— | $— | $11003 | $31444 |

---

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **March 31, 2025** | **March 31, 2025** | **March 31, 2025** | **March 31, 2025** | **March 31, 2025** | **March 31, 2025** |
| | **Current** | **30-59 days past due** | **60-89 days past due** | **90+ days past due and still accruing** | **Nonaccrual loans and leases** | **Total** |
| (dollars in thousands) | **Current** | **30-59 days past due** | **60-89 days past due** | **90+ days past due and still accruing** | **Nonaccrual loans and leases** | **Total** |
| Commercial mortgage | $1388 | $— | $959 | $— | $— | $2347 |
| Residential mortgage |  |  |  |  | 545 | 545 |
| Construction | 2869 |  |  |  | 4763 | 7632 |
| Commercial, industrial & other finance receivables | 1897 |  |  |  | 2772 | 4669 |
| Small business loans | 2505 |  |  |  | 2328 | 4833 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $8659 | $— | $959 | $— | $10408 | $20026 |

---

**(6)&nbsp;&nbsp;&nbsp;&nbsp;Short-Term Borrowings and Long-Term Debt**

The Corporation's short-term borrowings generally consist of federal funds purchased and short-term borrowings extended under agreements with the FHLB or other correspondent banks. The Corporation has four unsecured borrowing facilities with correspondent banks for up to $56 million in total. Federal funds purchased generally represent one-day borrowings. The Corporation had $0 and $0 in Federal funds purchased at March 31, 2026 and December 31, 2025, respectively. The Corporation also has a facility with the Federal Reserve Bank discount window of $4.3 million. This facility is fully secured by investment securities and pledged loans. There were no borrowings under this at March 31, 2026 and December 31, 2025. The Corporation has a revolving line of credit with ACBB of $5 million that is used to fund operating activities of the Corporation and had an outstanding balance of $0 at March 31, 2026.

The following table presents short-term borrowings at the dates indicated:

---

| | | | | |
|:---|:---|:---|:---|:---|
| *(dollars in thousands)* | **Maturity<br>date** | **Interest<br>rate** | **March 31,<br>2026** | **December 31,<br>2025** |
| FHLB Open Repo Plus Weekly | 6/15/2026 | 3.97% | $94999 | $89999 |
| FHLB Mid-term Repo Fixed | 7/14/2026 | 4.57% | 15245 | 15245 |
| ACBB Holding Company Revolving LOC | 7/24/2026 | 7.00% |  | 1500 |
| Total Short-Term Borrowings |  |  | $110244 | $106744 |

---

The following table presents long-term borrowings at the dates indicated:

---

| | | | | |
|:---|:---|:---|:---|:---|
| *(dollars in thousands)* | **Maturity<br>date** | **Interest<br>rate** | **March 31,<br>2026** | **December 31,<br>2025** |
| FHLB Mid-term Repo Fixed | 5/20/2027 | 4.70% | $10594 | $10594 |
| Total Long-Term Borrowings |  |  | $10594 | $10594 |

---

The FHLB has also issued $170.1 million of letters of credit to the Corporation for the benefit of the Corporation's public deposit funds and loan customers. These letters of credit expire throughout the remainder of 2026.

The Corporation has a maximum borrowing capacity with the FHLB of $732.0 million as of March 31, 2026 and $751.5 million as of December 31, 2025. All advances and letters of credit from the FHLB are secured by a blanket lien on non-pledged, mortgage-related loans and securities as part of the Corporation's borrowing agreement with the FHLB.

**(7)&nbsp;&nbsp;&nbsp;&nbsp;Servicing Assets**

The Corporation sells certain residential mortgage loans and the guaranteed portion of certain SBA loans to third parties and retains servicing rights and receives servicing fees. All such transfers are accounted for as sales. When the Corporation sells a residential mortgage loan, it does not retain any portion of that loan and its continuing involvement in such transfers is limited to certain servicing responsibilities. While the Corporation may retain a portion of certain sold SBA loans, its continuing involvement in the portion of the loan that was sold is limited to certain servicing responsibilities. When the contractual servicing fees on loans sold with servicing retained are expected to be more than adequate compensation to a servicer for performing the servicing, a capitalized servicing asset is recognized.

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

*Residential Mortgage Loans*

The related MSR asset is amortized over the period of the estimated future net servicing life of the underlying assets. MSRs are evaluated quarterly for impairment based upon the fair value of the rights as compared to their amortized cost. Impairment is recognized on the income statement to the extent the fair value is less than the capitalized amount of the MSR.

The Corporation serviced $10.2 million and $10.3 million of residential mortgage loans as of March 31, 2026 and December 31, 2025, respectively. During the three months ended March 31, 2026, the Corporation recognized servicing fee income of $2 thousand compared to $48 thousand during the three months ended March 31, 2025.

Changes in the MSR balance are summarized as follows:

---

| | | |
|:---|:---|:---|
| | **Three months ended<br>March 31,** | **Three months ended<br>March 31,** |
| *(dollars in thousands)* | **2026** | **2025** |
| Balance at beginning of the period | $86 | $1124 |
| Servicing rights capitalized | 3 |  |
| Amortization of servicing rights | (5) | (45) |
| Balance at end of the period | $84 | $1079 |

---

The decrease in MSR balance in the table above from March 31, 2025 to March 31, 2026 was the result of the Corporation's sale of residential mortgage loan servicing rights during the second quarter of 2025. During the second quarter of 2025 the Corporation sold approximately $979 thousand of residential mortgage loan servicing rights associated with $110.2 million of serviced loans.

The Corporation uses assumptions and estimates in determining the fair value of MSRs. These assumptions include prepayment speeds and discount rates. The assumptions used in the valuation were based on input from buyers, brokers and other qualified personnel, as well as market knowledge. At March 31, 2026, the key assumptions used to determine the fair value of the Corporation's MSRs included a lifetime constant prepayment rate equal to 8.53% and a discount rate equal to 9.50%. At December 31, 2025, the key assumptions used to determine the fair value of the Corporation's MSRs included a lifetime constant prepayment rate equal to 9.60% and a discount rate equal to 9.50%. As interest rates increased and the number of mortgage refinancings have declined, model inputs have been adjusted to align the MSRs fair value with market conditions.

The sensitivity of the current fair value of the residential mortgage servicing rights to immediate 10% and 20% adverse changes in key economic assumptions are included in the following table.

---

| | | |
|:---|:---|:---|
| *(dollars in thousands)* | **March 31,<br>2026** | **December 31,<br>2025** |
| Fair value of residential mortgage servicing rights | $119 | $114 |
| Weighted average life (months) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;46 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;43 |
| Prepayment speed | 8.53% | 9.60% |
| &nbsp;&nbsp;&nbsp;&nbsp;Impact on fair value: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10% adverse change | $(5) | $(5) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20% adverse change | (10) | (10) |
| Discount rate | 9.50% | 9.50% |
| &nbsp;&nbsp;&nbsp;&nbsp;Impact on fair value: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10% adverse change | $(5) | $(4) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20% adverse change | (9) | (9) |

---

The sensitivity calculations above are hypothetical and should not be considered to be predictive of future performance. As indicated, changes in fair value based on adverse changes in assumptions generally cannot be extrapolated because the relationship of the change in assumption to the change in fair value may not be linear. Also, in this table, the effect of an adverse variation in a particular assumption on the fair value of the MSRs is calculated without changing any other assumption; while in reality, changes in one factor may result in changes in another (for example, increases in market interest rates may result in lower prepayments), which may magnify or counteract the effect of the change.

*SBA Loans*

SBA loan servicing assets are amortized over the period of the estimated future net servicing life of the underlying assets. SBA loan servicing assets are evaluated quarterly for impairment based upon the fair value of the rights as compared to their amortized cost. Impairment is recognized on the income statement to the extent the fair value is less than the capitalized amount of the SBA loan

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

servicing asset. The Corporation serviced $296.0 million and $305.3 million of SBA loans, as of March 31, 2026 and December 31, 2025, respectively.

Changes in the SBA loan servicing asset balance are summarized as follows:

---

| | | |
|:---|:---|:---|
| | **Three months ended<br>March 31,** | **Three months ended<br>March 31,** |
| *(dollars in thousands)* | **2026** | **2025** |
| Balance at beginning of the period | $3846 | $3258 |
| Servicing rights capitalized | 126 | 228 |
| Amortization of servicing rights | (346) | (310) |
| Change in valuation allowance | (16) | 29 |
| Balance at end of the period | $3610 | $3205 |

---

Activity in the valuation allowance for SBA loan servicing assets was as follows:

---

| | | |
|:---|:---|:---|
| | **Three months ended<br>March 31,** | **Three months ended<br>March 31,** |
| *(dollars in thousands)* | **2026** | **2025** |
| Valuation allowance, beginning of period | $(39) | $(74) |
| Impairment | (15) |  |
| Recovery |  | 29 |
| Valuation allowance, end of period | $(54) | $(45) |

---

The Corporation uses assumptions and estimates in determining the fair value of SBA loan servicing rights. These assumptions include prepayment speeds, discount rates, and other assumptions. The assumptions used in the valuation were based on input from buyers, brokers and other qualified personnel, as well as market knowledge. At March 31, 2026, the key assumptions used to determine the fair value of the Corporation's SBA loan servicing rights included a lifetime constant prepayment rate equal to 17.78% and a discount rate equal to 12.00%. At December 31, 2025, the key assumptions used to determine the fair value of the Corporation's SBA loan servicing rights included a lifetime constant prepayment rate equal to 17.10% and a discount rate equal to 12.91%.

The sensitivity of the current fair value of the SBA loan servicing rights to immediate 10% and 20% adverse changes in key economic assumptions are included in the following table.

---

| | | |
|:---|:---|:---|
| *(dollars in thousands)* | **March 31,<br>2026** | **December 31,<br>2025** |
| Fair value of SBA loan servicing rights | $4398 | $4522 |
| Weighted average life (years) | 3.3 | 3.3 |
| Prepayment speed | 17.78% | 17.10% |
| &nbsp;&nbsp;&nbsp;&nbsp;Impact on fair value: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10% adverse change | $(206) | $(207) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20% adverse change | (394) | (397) |
| Discount rate | 12.00% | 12.91% |
| &nbsp;&nbsp;&nbsp;&nbsp;Impact on fair value: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10% adverse change | $(97) | $(101) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20% adverse change | (190) | (197) |

---

The sensitivity calculations above are hypothetical and should not be considered to be predictive of future performance. As indicated, changes in fair value based on adverse changes in assumptions generally cannot be extrapolated because the relationship of the change in assumption to the change in fair value may not be linear. Also, in this table, the effect of an adverse variation in a particular assumption on the fair value of the SBA servicing rights is calculated without changing any other assumption; while in reality, changes in one factor may result in changes in another (for example, increases in market interest rates may result in lower prepayments), which may magnify or counteract the effect of the change.

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

**(8)&nbsp;&nbsp;&nbsp;&nbsp;Fair Value Measurements and Disclosures**

The Corporation uses fair value measurements to record fair value adjustments to certain assets and liabilities. The fair value of a financial instrument is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is best determined based upon quoted market prices. However, in many instances, there are no quoted market prices for the Corporation's various financial instruments. In cases where quoted market prices are not available, fair values are based on estimates using present value or other valuation techniques. Those techniques are significantly affected by the assumptions used, including the discount rate and estimates of future cash flows. Accordingly, the fair value estimates may not be realized in an immediate settlement of the instrument.

The fair value guidance provides a consistent definition of fair value, which focuses on exit price in an orderly transaction (that is, not a forced liquidation or distressed sale) between market participants at the measurement date under current market conditions. If there has been a significant decrease in the volume and level of activity for the asset or liability, a change in valuation techniques or the use of multiple valuation techniques may be appropriate. In such instances, determining the price at which willing market participants would transact at the measurement date under current market conditions depends on the facts and circumstances and requires the use of significant judgment. The fair value is a reasonable point within the range that is most representative of fair value under current market conditions.

In accordance with this guidance, the Corporation groups its financial assets and financial liabilities measured at fair value in three levels, based on the markets in which the assets and liabilities are traded and the reliability of the assumptions used to determine fair value.

Level 1 – Valuation is based on quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.

Level 2 – Valuation is based on inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. The valuation may be based on quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability.

Level 3 – Valuation is based on unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which determination of fair value requires significant management judgment or estimation.

Following is a description of the valuation methodologies used for instruments measured at fair value on a recurring basis.

***Securities***

The fair value of securities available-for-sale (carried at fair value) and held to maturity (carried at amortized cost) are determined by matrix pricing (Level 2), which is a mathematical technique used widely in the industry to value debt securities without relying exclusively on quoted market prices for the specific securities but rather by relying on the securities' relationship to other benchmark quoted prices. The fair value of certain other securities available-for-sale (carried at fair value) are based on quoted prices obtained from dealers or brokers in active over-the-counter markets (Level 1).

***Mortgage Loans Held for Sale***

The fair value of loans held for sale is based on secondary market prices.

***Mortgage Loans Held for Investment***

The fair value of mortgage loans held for investment is based on the price secondary markets are currently offering for similar loans using observable market data.

***Derivative Financial Instruments***

The fair values of forward commitments and interest rate swaps are based on market pricing and therefore are considered Level 2. Derivatives classified as Level 3 consist of interest rate lock commitments related to mortgage loan commitments. The determination of fair value includes assumptions related to the likelihood that a commitment will ultimately result in a closed loan, which is a significant unobservable assumption. A significant increase or decrease in the external market price would result in a significantly higher or lower fair value measurement.

The following table presents the fair value of financial assets measured at fair value on a recurring basis by level within the fair value hierarchy at the dates indicated**:**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** |
| *(dollars in thousands)* | **Total** | **Level 1** | **Level 2** | **Level 3** |
| **Assets** |  |  |  |  |
| Securities available for sale: |  |  |  |  |
| U.S. asset backed securities | $25361 | $— | $25361 | $— |
| U.S. government agency MBS | 21816 |  | 21816 |  |

---

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** |
| *(dollars in thousands)* | **Total** | **Level 1** | **Level 2** | **Level 3** |
| U.S. government agency CMO | 69242 |  | 69242 |  |
| State and municipal securities | 39636 |  | 39636 |  |
| U.S. Treasuries | 16193 | 16193 |  |  |
| Non-U.S. government agency CMO | 7687 |  | 7687 |  |
| Corporate bonds | 16077 |  | 16077 |  |
| Equity investments | 2137 |  | 2137 |  |
| Mortgage loans held for sale | 38960 |  | 38960 |  |
| Mortgage loans held for investment | 14090 |  | 14090 |  |
| Interest rate lock commitments | 355 |  |  | 355 |
| Forward commitments | 130 |  | 130 |  |
| Customer derivatives - interest rate swaps | 1728 |  | 1728 |  |
| Fair Value Hedge | 13 |  | 13 |  |
| Total | $253425 | $16193 | $236877 | $355 |
| **Liabilities** |  |  |  |  |
| Interest rate lock commitments | $169 | $— | $— | $169 |
| Forward commitments | 13 |  | 13 |  |
| Customer derivatives - interest rate swaps | 1745 |  | 1745 |  |
| Customer derivatives - Risk Participation Agreements | 22 |  | 22 |  |
| Interest rate swaps | 123 |  | 123 |  |
| Total | $2072 | $— | $1903 | $169 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
| *(dollars in thousands)* | **Total** | **Level 1** | **Level 2** | **Level 3** |
| **Assets** |  |  |  |  |
| Securities available for sale: |  |  |  |  |
| U.S. asset backed securities | $26217 | $— | $26217 | $— |
| U.S. government agency MBS | 22351 |  | 22351 |  |
| U.S. government agency CMO | 66131 |  | 66131 |  |
| State and municipal securities | 40032 |  | 40032 |  |
| U.S. Treasuries | 16206 | 16206 |  |  |
| Non-U.S. government agency CMO | 8606 |  | 8606 |  |
| Corporate bonds | 13914 |  | 13914 |  |
| Equity investments | 2166 |  | 2166 |  |
| Mortgage loans held for sale | 33762 |  | 33762 |  |
| Mortgage loans held for investment | 14396 |  | 14396 |  |
| Interest rate lock commitments | 402 |  |  | 402 |
| Customer derivatives - interest rate swaps | 1909 |  | 1909 |  |
| Fair Value Hedge | 21 |  | 21 |  |
| Total | $246112 | $16206 | $229504 | $402 |
| **Liabilities** |  |  |  |  |
| Interest rate lock commitments | $13 | $— | $— | $13 |
| Forward commitments | 32 |  | 32 |  |
| Customer derivatives - interest rate swaps | 1929 |  | 1929 |  |
| Customer derivatives - Risk Participation Agreements | 23 |  | 23 |  |
| Interest rate swaps | 281 |  | 281 |  |
| Total | $2278 | $— | $2265 | $13 |

---

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

The following table presents assets measured at fair value on a nonrecurring basis at the dates indicated:

---

| | | |
|:---|:---|:---|
| *(dollars in thousands)* | **March 31,<br>2026** | **December 31,<br>2025** |
| Mortgage servicing rights | $84 | $86 |
| SBA loan servicing rights | 3610 | 3846 |
| OREO and other repossessed assets | 6009 | 5997 |
| Individually evaluated loans <sup>(1)</sup> |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commercial and industrial | 122 |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Construction | 3713 | 4430 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Small business loans | 2925 | 3745 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $16463 | $18103 |

---

(1) Individually evaluated loans are those in which the Corporation has measured impairment generally based on the fair value of the loan's collateral.

The following table details the valuation techniques for Level 3 assets.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| *(dollars in thousands)* | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** |
| **Financial Instrument** | **Fair Value** | **Valuation Technique** | **Unobservable Input** | **Range of Inputs** | **Weighted Average** |
| OREO and other repossessed assets | $6009 | Appraisal of collateral | Costs to sell | 6% - 13% discount | 10% |
| Individually evaluated loans | 6759 | Appraisal of collateral | Costs to sell | 10%-85% discount | 28% |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| *(dollars in thousands)* | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
| **Financial Instrument** | **Fair Value** | **Valuation Technique** | **Unobservable Input** | **Range of Inputs** | **Weighted Average** |
| OREO and other repossessed assets | $5997 | Appraisal of collateral | Costs to sell | 6% - 13% discount | 10% |
| Individually evaluated loans | 8175 | Appraisal of collateral | Costs to sell | 2%-48% discount | 24% |

---

Below is management's estimate of the fair value of all financial instruments, whether carried at cost or fair value on the Corporation's balance sheet. The following information should not be interpreted as an estimate of the fair value of the entire Corporation since a fair value calculation is only provided for a limited portion of the Corporation's assets and liabilities. Due to a wide range of valuation techniques and the degree of subjectivity used in making the estimates, comparisons between the Corporation's disclosures and those of other companies may not be meaningful. The following methods and assumptions were used to estimate the fair value of the Corporation's financial instruments:

***Cash and Cash Equivalents***

The carrying amounts reported in the balance sheet for cash and short-term instruments approximate those assets' fair values.

***Loans Receivable***

The fair value of loans receivable is estimated using discounted cash flow analyses, using market rates at the balance sheet date that reflect the credit and interest rate-risk inherent in the loans. Projected future cash flows are calculated based upon contractual maturity or call dates, projected repayments and prepayments of principal. Generally, for variable rate loans that reprice frequently and with no significant change in credit risk, fair values are based on carrying values. The fair value below is reflective of an exit price.

***Servicing Assets***

The Corporation estimates the fair value of mortgage servicing rights and SBA loan servicing rights using discounted cash flow models that calculate the present value of estimated future net servicing income. The model uses readily available prepayment speed assumptions for the interest rates of the portfolios serviced. These servicing rights are classified within Level 3 in the fair value hierarchy based upon management's assessment of the inputs. The Corporation reviews the servicing rights portfolios on a quarterly basis for impairment.

***Other Real Estate Owned***

Other real estate owned ("OREO") consists of loan collateral which has been repossessed through foreclosure or other measures. Initially, foreclosed assets are recorded at the fair value of the collateral less estimated selling costs. Subsequent to foreclosure, valuations are updated periodically and the assets may be marked down further, reflecting a new cost basis. The fair value of OREO was estimated using Level 3 inputs based on appraisals, letters of intent or agreement of sale received from third parties.

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

***Repossessed Assets***

Repossessed assets represents non-real estate assets that the Corporation has acquired by taking possession of the asset that collateralized a loan or lease. The Corporation reports repossessed assets at the fair value less cost to sell, adjusted periodically based on a current appraisal provided by a third party based on their assumptions and quoted market prices for similar assets, when available. Write-downs and any gain or loss upon the sale of repossessed assets is recorded in other noninterest income. The fair value of repossessed assets was estimated using Level 3 inputs based on appraisals, letters of intent or agreement of sale received from third parties.

***Individually Evaluated Loans***

Individually evaluated loans are those in which the Corporation has measured impairment generally based on the fair value of the loan's collateral. Fair value is generally determined based upon independent third party appraisals of the properties, or discounted cash flows based upon the expected proceeds. Non-real estate collateral may be valued using an appraisal, net book value per the borrower's financial statements, or aging reports, adjusted or discounted based on management's historical knowledge, changes in market conditions from the time of the valuation, and management's expertise and knowledge of the client and client's business. These assets are included as Level 3 fair values, based upon the lowest level of input that is significant to the fair value measurements. Individually evaluated loans are evaluated on a quarterly basis for additional impairment and adjusted in accordance with the ACL policy.

***Accrued Interest Receivable and Payable***

The carrying amount of accrued interest receivable and accrued interest payable approximates its fair value.

***Deposit Liabilities***

The fair values disclosed for demand deposits (e.g., interest and noninterest checking, passbook savings and money market accounts) are, by definition, equal to the amount payable on demand at the reporting date (i.e., their carrying amounts). Fair values for fixed-rate certificates of deposit are estimated using a discounted cash flow calculation that applies interest rates currently being offered in the market on certificates to a schedule of aggregated expected monthly maturities on time deposits.

***Short-Term Borrowings***

The carrying amounts of short-term borrowings approximate their fair values.

***Long-Term Debt***

Fair values of FHLB advances and the acquisition purchase note payable are estimated using discounted cash flow analysis, based on quoted prices for new FHLB advances with similar credit risk characteristics, terms and remaining maturity. These prices obtained from this active market represent a market value that is deemed to represent the transfer price if the liability were assumed by a third party.

***Subordinated Debt***

Fair values of junior subordinated debt are estimated using discounted cash flow analysis, based on market rates currently offered on such debt with similar credit risk characteristics, terms and remaining maturity.

***Off-Balance Sheet Financial Instruments***

Off-balance sheet instruments are primarily comprised of loan commitments, which are generally priced at market at the time of funding. Fees on commitments to extend credit and stand-by letters of credit are deemed to be immaterial and these instruments are expected to be settled at face value or expire unused. It is impractical to assign any fair value to these instruments and as a result they are not included in the table below. Fair values assigned to the notional value of interest rate lock commitments and forward sale contracts are based on market quotes.

***Derivative Financial Instruments***

The fair value of forward commitments and interest rate swaps is based on market pricing and therefore are considered Level 2. Derivatives classified as Level 3 consist of interest rate lock commitments related to mortgage loan commitments. The determination of fair value includes assumptions related to the likelihood that a commitment will ultimately result in a closed loan, which is a significant unobservable assumption. A significant increase or decrease in the external market price would result in a significantly higher or lower fair value measurement.

The following table presents the estimated fair values of the Corporation's financial instruments at the dates indicated:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Fair Value<br>Hierarchy Level** | **March 31, 2026** | **March 31, 2026** | **December 31, 2025** | **December 31, 2025** |
| *(dollars in thousands)* | **Fair Value<br>Hierarchy Level** | **Carrying<br>amount** | **Fair value** | **Carrying<br>amount** | **Fair value** |
| **Financial assets:** |  |  |  |  |  |
| Cash and cash equivalents | Level 1 | $28269 | $28269 | $35778 | $35778 |
| Mortgage loans held for sale | Level 2 | 38960 | 38960 | 33762 | 33762 |
| Loans and other finance receivables, net of ACL | Level 3 | 2146233 | 2116050 | 2134630 | 2108242 |

---

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| Mortgage loans held for investment | Level 2 | 14090 | 14090 | 14396 | 14396 |
| **Financial liabilities:** |  |  |  |  |  |
| Deposits | Level 2 | $2169960 | $2182600 | $2158128 | $2179800 |
| Borrowings | Level 2 | 120838 | 121000 | 117338 | 117700 |
| Subordinated debentures | Level 2 | 49675 | 49569 | 49853 | 49597 |

---

The following table includes a rollforward of interest rate lock commitments for which the Corporation utilized Level 3 inputs to determine fair value on a recurring basis for the periods indicated.

---

| | | |
|:---|:---|:---|
| | **Three months ended<br>March 31,** | **Three months ended<br>March 31,** |
| *(dollars in thousands)* | **2026** | **2025** |
| Balance at beginning of the period | $402 | $216 |
| Change in value | (47) | 148 |
| Balance at end of the period | $355 | $364 |

---

The following table details the valuation techniques for Level 3 interest rate lock commitments.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| *(dollars in thousands)* | **Fair Value** | **Valuation Technique** | **Significant Unobservable Input** | **Range of Inputs** | **Weighted Average** |
| March 31, 2026 | $355 | Market comparable pricing | Pull through | 1 - 99% | 85.52% |
| December 31, 2025 | 402 | Market comparable pricing | Pull through | 1 - 99% | 85.31% |

---

**(9)&nbsp;&nbsp;&nbsp;&nbsp;Derivative Financial Instruments**

*Risk Management Objective of Using Derivatives*

The Corporation is exposed to certain risk arising from both its business operations and economic conditions. The Corporation principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Corporation manages economic risks, including interest rate, liquidity, and credit risk primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Corporation enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Corporation's derivative financial instruments are used to manage differences in the amount, timing, and duration of the Corporation's known or expected cash receipts and its known or expected cash payments principally related to the Corporation's loan portfolio.

*Interest Rate Swaps*

The Corporation uses interest rate swap agreements to modify interest rate characteristics from variable to fixed or fixed to variable in order to reduce the impact of interest rate changes on future net interest income. The Corporation's credit exposure on interest rate swaps includes changes in fair value and any collateral that is held by a third party.

In June 2023 the Corporation entered into three interest rate swaps classified as cash flow hedges with notional amounts of $25 million each, to hedge the interest payments paid on short term borrowings. Under the terms of the three swap agreements, the Corporation pays average fixed rates of 4.070%, 4.027% and 4.117%, and receives variable rates in return indexed to SOFR. The swaps mature between May, June, and December 2026. The Corporation performed an assessment of the hedge for effectiveness at the inception of the hedge and performs an assessment on a recurring basis and determined that the derivative currently is and is expected to be highly effective in offsetting changes in cash flows of the hedged item. For the three months ended March 31, 2026, and 2025, approximately $122 thousand and $192 thousand, net of tax, is recorded in total comprehensive income as an unrealized gain and an unrealized loss, respectively. These amounts could differ from amounts actually recognized due to changes in interest rates, hedge de-designations and the addition of other hedges subsequent to March 31, 2026. At March 31, 2026 and December 31, 2025, the combined notional amount of the interest rate swaps was $75 million and $75 million, respectively, and the fair value was a liability of $123 thousand and $281 thousand, respectively.

In August 2024 the Corporation entered into an interest rate swap classified as a fair value hedge with a notional amount of $40 million, to hedge the interest payments received on a pool of residential mortgage loans held in portfolio. Under the terms of the swap agreement, the Corporation pays an average fixed rate of 3.60% and receives a variable rate in return indexed to SOFR. The swap matures August 2027. The Corporation performed an assessment of the hedge for effectiveness at the inception of the hedge and performs an assessment on a recurring basis and determined that the derivative currently is and is expected to be highly effective in offsetting changes in fair value of the hedged item. For the three months ended March 31, 2026, approximately $8 thousand, net of tax, is recorded as a fair values adjustment. These amounts could differ from amounts actually recognized due to changes in interest rates, hedge de-designations and the addition of other hedges subsequent to March 31, 2026.

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

*Mortgage Banking Derivatives*

In connection with its mortgage banking activities, the Corporation enters into commitments to originate certain fixed rate residential mortgage loans for customers, also referred to as interest rate locks. In addition, the Corporation may enter into forward commitments for the future sales or purchases of mortgage-backed securities to or from third-party counterparties to hedge the effect of changes in interest rates on the values of both the interest rate locks and mortgage loans held for sale. Forward sales commitments may also be in the form of commitments to sell individual mortgage loans or interest rate locks at a fixed price at a future date. The amount necessary to settle each interest rate lock is based on the price that secondary market investors would pay for loans with similar characteristics, including interest rate and term, as of the date fair value is measured. Interest rate lock commitments and forward commitments are recorded within other assets/liabilities on the consolidated balance sheets, with changes in fair values during the period recorded within net change in the fair value of derivative instruments on the consolidated statements of income.

*Customer Derivatives* 

Derivatives not designated as hedges are not speculative and result from a service the Corporation provides to certain customers to swap a fixed rate product for a variable rate product, or vice versa. The Corporation executes interest rate derivatives with commercial banking customers to facilitate their respective risk management strategies. Those interest rate derivatives are simultaneously hedged by offsetting derivatives that the Corporation executes with a third party, such that the Corporation minimizes its net interest rate risk exposure resulting from such transactions. As the interest rate derivatives associated with this program do not meet the strict hedge accounting requirements, changes in the fair value of both the customer derivatives and the offsetting derivatives are recognized directly in earnings.

The following table presents a summary of notional amounts and fair values of derivative financial instruments at the dates indicated:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **March 31, 2026** | **March 31, 2026** | **December 31, 2025** | **December 31, 2025** |
| *(dollars in thousands)* | **Balance Sheet Line Item** | **Notional Amount** | **Asset (Liability) Fair Value** | **Notional Amount** | **Asset (Liability) Fair Value** |
| Interest Rate Lock Commitments | Interest Rate Lock Commitments | Interest Rate Lock Commitments | Interest Rate Lock Commitments | Interest Rate Lock Commitments | Interest Rate Lock Commitments |
| Positive fair values | Other assets | $60047 | $355 | $40370 | $402 |
| Negative fair values | Other liabilities | 27761 | (169) | 2735 | (13) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total |  | $87808 | $186 | $43105 | $389 |
| Forward Commitments |  |  |  |  |  |
| Positive fair values | Other assets | $13000 | $130 | $— | $— |
| Negative fair values | Other liabilities | 4500 | (13) | 8000 | (32) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total |  | $17500 | $117 | $8000 | $(32) |
| Customer Derivatives - Interest Rate Swaps | Customer Derivatives - Interest Rate Swaps | Customer Derivatives - Interest Rate Swaps | Customer Derivatives - Interest Rate Swaps | Customer Derivatives - Interest Rate Swaps | Customer Derivatives - Interest Rate Swaps |
| Positive fair values | Other assets | $53413 | $1728 | $53954 | $1909 |
| Negative fair values | Other liabilities | 53413 | (1745) | 53954 | (1929) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total |  | $106826 | $(17) | $107908 | $(20) |
| Customer Derivatives - Risk Participation Agreements | Customer Derivatives - Risk Participation Agreements | Customer Derivatives - Risk Participation Agreements | Customer Derivatives - Risk Participation Agreements | Customer Derivatives - Risk Participation Agreements | Customer Derivatives - Risk Participation Agreements |
| Positive fair values | Other assets | $— | $— | $— | $— |
| Negative fair values | Other liabilities | 29434 | (22) | 24166 | (23) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total |  | $29434 | $(22) | $24166 | $(23) |
| Fair Value Hedge |  |  |  |  |  |
| Positive fair values | Other assets | $40000 | $13 | $40000 | $21 |
| Negative fair values | Other liabilities |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total |  | $40000 | $13 | $40000 | $21 |
| Interest Rate Swaps |  |  |  |  |  |
| Positive fair values | Other assets | $— | $— | $— | $— |
| Negative fair values | Other liabilities | 75000 | (123) | 75000 | (281) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total |  | $75000 | $(123) | $75000 | $(281) |
| Total derivative financial instruments |  | $356568 | $154 | $298179 | $54 |

---

Interest rate lock commitments are considered Level 3 in the fair value hierarchy, while the forward commitments and interest rate swaps are considered Level 2 in the fair value hierarchy.

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

The following table presents a summary of the net change in the fair value of derivative instruments:

---

| | | |
|:---|:---|:---|
| | **Three months ended<br>March 31,** | **Three months ended<br>March 31,** |
| *(dollars in thousands)* | **2026** | **2025** |
| Interest Rate Lock Commitments | $(203) | $102 |
| Forward Commitments | 149 | (30) |
| Customer Derivatives - Interest Rate Swaps | 3 | (33) |
| Customer Derivatives - Risk Participation Agreements | 1 | 80 |
| Net change in the fair value of derivative instruments | $(50) | $119 |

---

Net realized gains on derivative hedging activities were $18 thousand for the three months ended March 31, 2026, and net realized gains of $21 thousand for the three months ended March 31, 2025, and are included in non-interest income in the consolidated statements of income.

**(10)&nbsp;&nbsp;&nbsp;&nbsp;Segments**

ASC Topic 280 – Segment Reporting identifies operating segments as components of an enterprise which are evaluated regularly by the Corporation's Chief Operating Decision Maker, our Chief Executive Officer, in deciding how to allocate resources and assess performance. The Corporation has applied the aggregation criterion set forth in this codification to the results of its operations.

Our Banking segment ("Bank") consists of commercial and retail banking. The Banking segment generates interest income from its lending and investing activities and is dependent on the gathering of lower cost deposits from its branch network or borrowed funds from other sources for funding its loans, resulting in the generation of net interest income. The Banking segment also derives revenues from other sources including gains on the sale of SBA loans, sales of available for sale investment securities, service charges on deposit accounts, cash sweep fees, overdraft fees, BOLI income, title insurance fees, and other less significant non-interest income. Interest expense, provisions for credit losses, and payroll provide the significant expenses in the banking operation.

Meridian Wealth ("Wealth"), a registered investment advisor and wholly-owned subsidiary of the Bank, provides a comprehensive array of wealth management services and products and the trusted guidance to help its clients and our banking customers prepare for the future. Segment income before income taxes is used to assess the performance of the wealth segment by monitoring the generation of wealth management income as the wealth segment generates non-interest income through advisory fees. The cost of marketing, business development, and payroll provide the significant expenses in wealth.

Meridian's mortgage banking segment ("Mortgage") consists of 7 loan production offices throughout suburban Philadelphia and Maryland. Segment income before income taxes is used to assess the performance of the mortgage banking segment by monitoring the gains received on loan sales. The Mortgage segment originates 1 – 4 family residential mortgages and sells nearly all of its production to third party investors. The unit generates net interest income on the loans it originates and holds temporarily, then earns fee income (primarily gain on sales) at the time of the sale. The unit also recognizes income from document preparation fees, changes in portfolio pipeline fair values and related net hedging gains (losses). The cost of loans sales and payroll provide the significant expenses in mortgage banking.

The table below summarizes income and expenses, directly attributable to each business line, which have been included in the statement of operations. Total assets for each segment is also provided.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Segment Information** | **Segment Information** | **Segment Information** | **Segment Information** | **Segment Information** | **Segment Information** | **Segment Information** | **Segment Information** |
| | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** |
| *(dollars in thousands)* | **Bank** | **Wealth** | **Mortgage** | **Total** | **Bank** | **Wealth** | **Mortgage** | **Total** |
| Interest income | $40374 | $— | $338 | $40712 | $38835 | $— | $333 | $39168 |
| Interest expense | 17302 | (60) | 268 | 17510 | 19129 | (9) | 272 | 19392 |
| Net interest income | 23072 | 60 | 70 | 23202 | 19706 | 9 | 61 | 19776 |
| Provision for credit losses | 7493 |  |  | 7493 | 5212 |  |  | 5212 |
| Net interest income after provision | 15579 | 60 | 70 | 15709 | 14494 | 9 | 61 | 14564 |
| Non-interest Income: |  |  |  |  |  |  |  |  |
| Mortgage banking income | 45 |  | 4483 | 4528 | 18 |  | 3375 | 3393 |
| Wealth management income |  | 1729 |  | 1729 |  | 1535 |  | 1535 |
| SBA loan income | 150 |  |  | 150 | 748 |  |  | 748 |
| Loss on sale of MSRs |  |  | (159) | (159) | (52) |  |  | (52) |
| Net change in fair values | 26 |  | (496) | (470) | 77 |  | 344 | 421 |
| Net gain on hedging activity |  |  | 18 | 18 |  |  | 21 | 21 |
| Other | 1177 |  | 64 | 1241 | 1121 |  | 137 | 1258 |

---

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| Non-interest income | 1398 | 1729 | 3910 | 7037 | 1912 | 1535 | 3877 | 7324 |
| Non-interest expense: |  |  |  |  |  |  |  |  |
| Salaries and employee benefits | 7534 | 682 | 4170 | 12386 | 7049 | 560 | 3776 | 11385 |
| Occupancy and equipment | 919 | 18 | 246 | 1183 | 795 | 7 | 536 | 1338 |
| Professional fees | 814 | 50 | 110 | 974 | 677 | 11 | 75 | 763 |
| Data processing and software | 1553 | 46 | 374 | 1973 | 1065 | 43 | 371 | 1479 |
| Advertising and promotion | 495 | 78 | 119 | 692 | 591 | 93 | 95 | 779 |
| Pennsylvania bank shares tax | 254 | 4 |  | 258 | 264 | 5 |  | 269 |
| Other | 2388 | 100 | 204 | 2692 | 2317 | 99 | 314 | 2730 |
| Non-interest expense | 13957 | 978 | 5223 | 20158 | 12758 | 818 | 5167 | 18743 |
| Income before income taxes | $3020 | $811 | $(1243) | $2588 | $3648 | $726 | $(1229) | $3145 |
| Total Assets | $2496596 | $13243 | $66742 | $2576581 | $2483477 | $11243 | $34168 | $2528888 |

---

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.**

You should read the following discussion and analysis in conjunction with the unaudited consolidated interim financial statements and related notes contained in Part I, Item 1 of this Quarterly Report on Form 10-Q and the audited consolidated financial statements and the related notes and the discussion under the heading "Management's Discussion and Analysis of Financial Condition and Results of Operations" for the year ended December 31, 2025 included in Meridian Corporation's Annual Report on Form 10-K filed with the SEC.

**Forward-Looking Statements**

Meridian Corporation may from time to time make written or oral "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include statements with respect to Meridian Corporation's strategies, goals, beliefs, expectations, estimates, intentions, capital raising efforts, financial condition and results of operations, future performance and business. Statements preceded by, followed by, or that include the words "may," "could," "should," "pro forma," "looking forward," "would," "believe," "expect," "anticipate," "estimate," "intend," "plan," or similar expressions generally indicate a forward-looking statement. These forward-looking statements involve risks and uncertainties that are subject to change based on various important factors (some of which, in whole or in part, are beyond Meridian Corporation's control). Numerous competitive, economic, regulatory, legal and technological factors, risks and uncertainties that could cause actual results to differ materially include, without limitation: credit losses and the credit risk of our commercial and consumer loan products; changes in the level of charge-offs and changes in estimates of the adequacy of the allowance for credit losses, or ACL, including the timing of third-party appraisals and loan valuations from lead financial institutions in which we are a loan participant; cyber-security concerns; rapid technological developments and changes, including the development and use of artificial intelligence in business processes, services, and products; increased competitive pressures; changes in spreads on interest-earning assets and interest-bearing liabilities; changes in general economic conditions and conditions within the securities markets; escalating tariff and other trade policies and the resulting impacts on market volatility and global trade; the impact of uncertain or changing political conditions or any current or future federal government shutdown and uncertainty regarding the federal government's debt limit; geopolitical conditions, including acts or threats of terrorism, actions taken by the United States or other governments in response to acts or threats of terrorism and military conflicts, including the ongoing conflict in the Middle East, which could impact economic conditions in the United States; unanticipated changes in our liquidity position; unanticipated changes in regulatory and governmental policies impacting interest rates and financial markets; legislation affecting the financial services industry as a whole, and Meridian Corporation, in particular; changes in accounting policies, practices or guidance; developments affecting the industry and the soundness of financial institutions and further disruption to the economy and U.S. banking system; among others, could cause Meridian Corporation's financial performance to differ materially from the goals, plans, objectives, intentions and expectations expressed in such forward-looking statements.

Meridian Corporation cautions that the foregoing factors are not exclusive, and neither such factors nor any such forward-looking statement takes into account the impact of any future events. All forward-looking statements and information set forth herein are based on management's current beliefs and assumptions as of the date hereof and speak only as of the date they are made. For a more complete discussion of the assumptions, risks and uncertainties related to our business, you are encouraged to review Meridian Corporation's filings with the SEC, including our Annual Report on Form 10-K for the year ended December 31, 2025 and subsequently filed quarterly reports on Form 10-Q and current reports on Form 8-K that update or provide information in addition to the information included in the Form 10-K and Form 10-Q filings, if any. Meridian Corporation does not undertake to update any forward-looking statement whether written or oral, that may be made from time to time by Meridian Corporation or by or on behalf of Meridian Bank.

**Critical Accounting Policies and Estimates**

Our critical accounting policies are described in detail in the "Critical Accounting Policies" section within Item 7 of our 2025 Annual Form 10-K. The SEC defines "critical accounting policies" as those that require application of management's most difficult, subjective or

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain and may change in future periods. Management considers the measurement of the allowance for credit losses to be a critical accounting policy.

**Executive Overview**

The following items highlight the Corporation's changes in its financial condition as of March 31, 2026 compared to December 31, 2025 and the results of operations for the three months ended March 31, 2026 compared to the same period in 2025. More detailed information related to these highlights can be found in the sections that follow.

**Changes in Financial Condition - March 31, 2026 Compared to December 31, 2025**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**•** Total assets increased $14.6 million, or 0.6%, to $2.6 billion as of March 31, 2026.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Portfolio loans increased $11.1 million, or 0.5%, to $2.2 billion as of March 31, 2026.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**•** Mortgage loans held for sale increased $5.2 million, or 15.4%, to $39.0 million as of March 31, 2026.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**•** Total deposits increased $11.8 million or 0.5% to $2.2 billion as of March 31, 2026.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**•** The Corporation earned net income of $2.0 million during the three months ended March 31, 2026 and returned $1.7 million of capital to Meridian shareholders during the three months ended March 31, 2026 through a $0.14 dividend per share in the first quarter of the year.

**Three Month Results of Operations - March 31, 2026 Compared to March 31, 2025**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Net income was $2.0 million, or $0.17 per diluted share, down $393 thousand, or 16.4%, driven by a higher provision for credit losses, lower non-interest income, and higher non-interest expense, offset somewhat by improved net interest income.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**•** The return on average assets and return on average equity were 0.32% and 4.02%, respectively, for the first quarter 2026, compared to 0.40% and 5.57%, respectively, for the first quarter 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Net interest income increased $3.4 million, or 17.3%, to $23.2 million and the net interest margin increased to 3.82% from 3.46%, due to the impact of deposit and borrowing cost declines as well as the increase in average noninterest-bearing deposits over the period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**•** The overall provision for credit losses increased $2.3 million when comparing the first quarter 2026 to the first quarter 2025. The increase of $4.9 million in net charge-offs over this period was the driver for the increase in provision for credit losses, and was led by a $3.9 million charge-off taken during the first quarter 2026 on a loan purchase participation from another financial institution.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Non-interest income decreased $287 thousand, or 3.9%, to $7.0 million driven by a $598 thousand decline in SBA loan income, a decrease of $685 thousand in fair value adjustments related to the mortgage banking segment. These declines in non-interest income were partially offset by a $1.1 million increase in mortgage banking income.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Non-interest expense increased $1.4 million, or 7.5%, to $20.2 million due to a $1.0 million increase in salaries and employee benefits, and an increase of $494 thousand in data processing and software expense.

**Key Performance Ratios**

The following table presents key financial performance ratios for the periods indicated:

---

| | | |
|:---|:---|:---|
| | **Three months ended<br>March 31,** | **Three months ended<br>March 31,** |
| | **2026** | **2025** |
| Return on average assets, annualized | 0.32% | 0.40% |
| Return on average equity, annualized | 4.02% | 5.57% |
| Net interest margin (tax effected yield) | 3.82% | 3.46% |
| Basic earnings per share | $0.17 | $0.21 |
| Diluted earnings per share | $0.17 | $0.21 |

---

The following table presents certain key period-end balances and ratios at the dates indicated:

---

| | | |
|:---|:---|:---|
| *(dollars in thousands, except per share amounts)* | **March 31,<br>2026** | **December 31,<br>2025** |
| Book value per common share | $16.86 | $16.89 |
| Tangible book value per common share <sup>(1)</sup> | $16.57 | $16.59 |
| Allowance as a percentage of loans and other finance receivables (excluding loans at fair value) | 0.98% | 1.00% |
| Tier I capital to risk weighted assets | 8.63% | 8.68% |
| Tangible common equity to tangible assets ratio <sup>(1)</sup>  | 7.65% | 7.67% |
| Loans and other finance receivables, net of fees and costs | $2181575 | $2170600 |

---

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

---

| | | |
|:---|:---|:---|
| Total assets | $2576581.0 | $2561995.0 |
| Total stockholders' equity | $200225.0 | $199716.0 |

---

(1) Non-GAAP financial measure. See "Non-GAAP Financial Measures" below for Non-GAAP to GAAP reconciliation.

**Components of Net Income**

Net income is comprised of five major elements:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Net Interest Income**, or the difference between the interest income earned on loans, leases, other finance receivables, and investments and the interest expense paid on deposits and borrowed funds;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Provision For Credit Losses**, or the amount added to the Allowance to provide for current expected credit losses on portfolio loans and other finance receivables;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Non-interest Income,** which is made up primarily of mortgage banking income, wealth management income, SBA loan sale income, fair value adjustments, gains and losses from the sale of loans, gains and losses from the sale of investment securities available for sale and other fees from loan and deposit services;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Non-interest Expense**, which consists primarily of salaries and employee benefits, occupancy, professional fees, advertising & promotion, data processing and software expense, loan expenses, and other operating expenses; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Income Taxes**, which include state and federal jurisdictions.

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

**NET INTEREST INCOME**

Net interest income is an integral source of the Corporation's revenue. The tables below present a summary for the three months ended March 31, 2026 and 2025, of the Corporation's average balances and yields earned on its interest-earning assets and the rates paid on its interest-bearing liabilities. The net interest margin is the net interest income as a percentage of average interest-earning assets. The net interest spread is the difference between the weighted average yield on interest-earning assets and the weighted average cost of interest-bearing liabilities. The difference between the net interest margin and the net interest spread is the result of net free funding sources such as non-interest bearing deposits and stockholders' equity.

**Analyses of Interest Rates and Interest Differential**

The table below present the major asset and liability categories on an average daily balance basis for the periods presented, along with interest income, interest expense and key rates and yields on a tax equivalent basis.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **For the Three Months Ended March 31,** | **For the Three Months Ended March 31,** | **For the Three Months Ended March 31,** | **For the Three Months Ended March 31,** | **For the Three Months Ended March 31,** | **For the Three Months Ended March 31,** |
| *(dollars in thousands)* | **2026** | **2026** | **2026** | **2025** | **2025** | **2025** |
| *(dollars in thousands)* | **Average Balance** | **Interest Income/ Expense** | **Yields/ Rates** | **Average Balance** | **Interest Income/ Expense** | **Yields/ Rates** |
| **Assets:** |  |  |  |  |  |  |
| Cash and cash equivalents | $42349 | $398 | 3.81% | $56170 | $613 | 4.43% |
| Investment securities - taxable | 175297 | 1847 | 4.27 | 159051 | 1693 | 4.32 |
| Investment securities - tax exempt <sup>(1)</sup> | 55292 | 396 | 2.90 | 54723 | 387 | 2.87 |
| Loans held for sale | 23783 | 338 | 5.76 | 20604 | 333 | 6.55 |
| Loans held for investment | 2175938 | 37806 | 7.05 | 2039676 | 36218 | 7.20 |
| Total loans | 2199721 | 38144 | 7.03 | 2060280 | 36551 | 7.19 |
| Total interest-earning assets | 2472659 | 40785 | 6.69% | 2330224 | 39244 | 6.83% |
| Noninterest earning assets | 101609 |  |  | 90347 |  |  |
| Total assets | $2574268 |  |  | $2420571 |  |  |
| **Liabilities and stockholders' equity:** | **Liabilities and stockholders' equity:** |  |  |  |  |  |
| Interest-bearing demand deposits | $149192 | $1040 | 2.83% | $150980 | $1229 | 3.30% |
| Money market and savings deposits | 1025036 | 7070 | 2.80 | 919731 | 7808 | 3.44 |
| Time deposits | 747406 | 7113 | 3.86 | 721336 | 7831 | 4.40 |
| Total interest - bearing deposits | 1921634 | 15223 | 3.21 | 1792047 | 16868 | 3.82 |
| Borrowings | 112028 | 1293 | 4.68 | 123677 | 1469 | 4.82 |
| Subordinated debentures | 49722 | 994 | 8.11 | 49749 | 1055 | 8.60 |
| Total interest-bearing liabilities | 2083384 | 17510 | 3.41 | 1965473 | 19392 | 4.00 |
| Noninterest-bearing deposits | 250203 |  |  | 244161 |  |  |
| Other noninterest-bearing liabilities | 38104 |  |  | 36203 |  |  |
| Total liabilities | 2371691 |  |  | 2245837 |  |  |
| Total stockholders' equity | 202577 |  |  | 174734 |  |  |
| Total stockholders' equity and liabilities | $2574268 |  |  | $2420571 |  |  |
| Net interest income and spread <sup>(1)</sup> | Net interest income and spread <sup>(1)</sup> | $23275 | 3.28 |  | $19852 | 2.83 |
| Net interest margin <sup>(1)</sup> |  |  | 3.82% |  |  | 3.46% |

---

(1)Yields and net interest income are reflected on a tax-equivalent basis.

.

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

**Rate / Volume Analysis** 

The rate/volume analysis table below analyzes dollar changes in the components of interest income and interest expense as they relate to the change in balances (volume) and the change in interest rates (rate) of tax-equivalent net interest income for the three months ended March 31, 2026 as compared to the same period in 2025, allocated by rate and volume. Changes in interest income and/or expense attributable to both rate and volume have been allocated proportionately based on the relationship of the absolute dollar amount of the change in each category.

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026 Compared to 2025** | **2026 Compared to 2025** | **2026 Compared to 2025** |
| *(dollars in thousands)* | **Rate** | **Volume** | **Total** |
| **Interest income:** |  |  |  |
| Cash and cash equivalents | $(78) | $(137) | $(215) |
| Investment securities - taxable | (17) | 171 | 154 |
| Investment securities - tax exempt <sup>(1)</sup> | 5 | 4 | 9 |
| Loans held for sale | (43) | 48 | 5 |
| Loans held for investment | (792) | 2380 | 1588 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total loans | (835) | 2428 | 1593 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total interest income | $(925) | $2466 | $1541 |
| **Interest expense:** |  |  |  |
| Interest-bearing demand deposits | $(175) | $(14) | $(189) |
| Money market and savings deposits | (1568) | 830 | (738) |
| Time deposits | (993) | 275 | (718) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total interest - bearing deposits | (2736) | 1091 | (1645) |
| Borrowings | (41) | (135) | (176) |
| Subordinated debentures | (60) | (1) | (61) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total interest expense | $(2837) | $955 | $(1882) |
| Interest differential | $1912 | $1511 | $3423 |

---

(1)Yields and net interest income are reflected on a tax-equivalent basis.

**Three Months Ended March 31, 2026 Compared to Three Months Ended March 31, 2025**

For the three months ended March 31, 2026 as compared to the same period in 2025, tax-equivalent interest income increased $1.5 million as favorable volume changes contributed $2.5 million to interest income, partially offset by rate changes that had a $925 thousand unfavorable impact on interest income. The loans held for investment average balances increased $136.3 million, leading to a favorable volume impact on interest income of $2.4 million, while the increase in loans held for sale average balances of $3.2 million had a favorable impact on interest income of $48 thousand. Growth in the loans held for investment portfolio was led by average balance increases in construction loans ($82.9 million), commercial mortgage loans ($40.3 million), commercial and industrial loans ($27.6 million), and home equity lines and loans ($15.6 million). The change in rates led to decreased yields on loans held for sale (down 79 basis points) and loans held for investment (down 15 basis points) that unfavorably impact interest income by $835 thousand, overall.

On the funding side, overall interest expense decreased $1.9 million, largely driven by a continuation in the decline of the cost of deposits and borrowings driven by the Fed's rates cuts over the last year. The cost of deposits were down across the board, leading to a $1.6 million decrease to interest expense. The cost of interest-bearing demand deposits, money market and savings accounts and time deposits decreased 47 basis points, 64 basis points and 54 basis points, respectively. These deposit cost declines were partially offset by overall volume increases as the average balances on money market and savings accounts increased $105.3 million, and the average balances on time increased $26.1 million.

The cost of borrowings decreased by 14 basis points, while the cost of subordinated debentures decreased 49 basis points as the interest rate on the $40 million in floating rate 2019 Debentures was lower in the current quarter, contributing a $60 thousand decrease to interest expense. Borrowing balances decreased $11.6 million on average.

Overall, the $3.4 million increase in net interest income over this period was primarily driven by rate changes and secondarily through volume changes.

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

**PROVISION FOR CREDIT LOSSES**

**Three Months Ended March 31, 2026 Compared to Three Months Ended March 31, 2025**

The total provision for credit losses increased $2.3 million on a net basis for the three months ended March 31, 2026, compared to the three months ended March 31, 2025. The provision on funded loans increased $2.2 million over the three month comparable period in 2025 driven largely by an increase of $3.9 million in commercial mortgage charge-offs from a loan participated to us by another financial institution that became non-performing as of March 31, 2026. There was a $55 thousand provision on unfunded loan commitments for the three months ended March 31, 2026, while for the three months March 31, 2025 there was no provision on unfunded loan commitments.

**NON-INTEREST INCOME**

**Three Months Ended March 31, 2026 Compared to Three Months Ended March 31, 2025**

The following table presents the components of non-interest income for the periods indicated:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | | |
| *(dollars in thousands)* | **March 31,<br>2026** | **March 31,<br>2025** | **$ Change** | **% Change** |
| Mortgage banking income | $4528 | $3393 | $1135 | 33.5% |
| Wealth management income | 1729 | 1535 | 194 | 12.6% |
| SBA loan income | 150 | 748 | (598) | (79.9)% |
| Earnings on investment in life insurance | 272 | 222 | 50 | 22.5% |
| Net loss on sale of MSRs | (159) | (52) | (107) | 205.8% |
| Net change in the fair value of derivative instruments | (51) | 149 | (200) | (134.2)% |
| Net change in the fair value of loans held-for-sale | (380) | 102 | (482) | (472.5)% |
| Net change in the fair value of loans held-for-investment | (39) | 170 | (209) | (122.9)% |
| Net gain on hedging activity | 18 | 21 | (3) | (14.3)% |
| Other | 969 | 1036 | (67) | (6.5)% |
| Total non-interest income | $7037 | $7324 | $(287) | (3.9)% |

---

Mortgage banking income increased $1.1 million over the comparable quarterly period as the volume of loans sold increased by $18.4 million, with a 28 basis point increase in the sales margin. Despite this 33.5% increase in mortgage banking income, total non-interest income decreased $287 thousand largely due to negative fair value adjustments, a decrease in SBA loan income, and an increase in net loss recorded on the sale of MSRs.

SBA loan income also decreased $598 thousand over this period due to a decline in the volume of SBA loans sold. The value of SBA loans sold for the quarter-ended March 31, 2026 was $5.4 million, or 44.8%, lower than the quarter-ended March 31, 2025, while the gross margin on sale was 8.5% for the quarter-ended March 31, 2026 compared to 8.7% for the quarter-ended March 31, 2025, down slightly.

**NON-INTEREST EXPENSE**

**Three Months Ended March 31, 2026 Compared to Three Months Ended March 31, 2025**

The following table presents the components of non-interest expense for the periods indicated:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | | |
| *(dollars in thousands)* | **March 31,<br>2026** | **March 31,<br>2025** | **$ Change** | **% Change** |
| Salaries and employee benefits | $12386 | $11385 | $1001 | 8.8% |
| Occupancy and equipment | 1183 | 1338 | (155) | (11.6)% |
| Professional fees | 974 | 763 | 211 | 27.7% |
| Data processing and software | 1973 | 1479 | 494 | 33.4% |
| Advertising and promotion | 692 | 779 | (87) | (11.2)% |
| Pennsylvania bank shares tax | 258 | 269 | (11) | (4.1)% |
| Other | 2692 | 2730 | (38) | (1.4)% |
| Total non-interest expense | $20158 | $18743 | $1415 | 7.5% |

---

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

Total non-interest expense increased $1.4 million, or 7.5%, primarily as the result of an increase in salaries and employee benefits and data processing and software expense, partially offset by a decline in occupancy and equipment expense. Salaries and employee benefits increased $1.0 million due largely to overall employee merit, benefit, and tax related increases for existing employees, as well as an increase of six full-time equivalent employees, combined with an increase in mortgage segment related commissions and other benefits. Data processing and software expenses increased $494 thousand, reflecting greater customer transaction activity and Meridian's ongoing commitment to technology investments. Professional fees increased $211 thousand, largely related to loan work out expenses. Meanwhile, there was a decline of $155 thousand in occupancy and equipment expense largely due to a prior year early termination of office lease space.

**INCOME TAX EXPENSE**

Income tax expense for the three months ended March 31, 2026 was $582 thousand, as compared to $746 thousand for the same period in 2025. Our effective tax rate was 22.5% for the three months ended March 31, 2026, compared to 23.7% for the same period in 2025. While income tax expense decreased primarily due to the decrease in income before income taxes, the effective tax rate decreased slightly due to the impact of tax expense recognized in the prior-quarter related to the surrender of certain bank owned life insurance policies.

**BALANCE SHEET ANALYSIS**

As of March 31, 2026, total assets were $2.6 billion which increased $14.6 million, or 0.6%, from December 31, 2025. This increase in assets over the prior period was due primarily to loan portfolio growth, as detailed in the following table:

---

| | | | | |
|:---|:---|:---|:---|:---|
| *(dollars in thousands)* | **March 31,<br>2026** | **December 31,<br>2025** | **$ Change** | **% Change** |
| Mortgage loans held for sale | $38960 | $33762 | $5198 | 15.4% |
| Real estate loans: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Commercial mortgage | 870544 | 879440 | (8896) | (1.0) |
| &nbsp;&nbsp;&nbsp;&nbsp; Home equity lines and loans | 109795 | 107002 | 2793 | 2.6 |
| &nbsp;&nbsp;&nbsp;&nbsp; Residential mortgage | 235067 | 236135 | (1068) | (0.5) |
| Construction | 343376 | 330543 | 12833 | 3.9 |
| &nbsp;&nbsp;&nbsp;&nbsp; Total real estate loans | 1558782 | 1553120 | 5662 | 0.4 |
| Commercial, industrial & other finance receivables | 444395 | 428981 | 15414 | 3.6 |
| Small business loans | 134468 | 139765 | (5297) | (3.8) |
| Consumer | 303 | 329 | (26) | (7.9) |
| Leases, net | 40837 | 45489 | (4652) | (10.2) |
| &nbsp;&nbsp;&nbsp;&nbsp; Loans and other finance receivables | $2178785 | $2167684 | $11101 | 0.5 |
| &nbsp;&nbsp;&nbsp;&nbsp; Total loans and other finance receivables | $2217745 | $2201446 | $16299 | 0.7% |

---

Total loans and other finance receivables increased $11.1 million, to $2.2 billion as of March 31, 2026, from $2.2 billion as of December 31, 2025. Overall portfolio loan growth was 0.5% since December 31, 2025, or 2.0% on an annualized basis for 2026. Construction loans increased $12.8 million, or 3.9%, and commercial and industrial loans increased $15.4 million, or 3.6%. While commercial real estate loans decreased $8.9 million, or 1.0%, and SBA loans decreased $5.3 million, or 3.8% due to loan sales described above.

As of March 31, 2026, included within the commercial real estate loans total of $870.5 million was $290.3 million of owner-occupied commercial loans, as well as $104.2 million of multi-family loans. Nearly all of the multi-family real estate loans are on properties located in Philadelphia and surrounding counties we service.

The following table presents the major categories of deposits at the dates indicated:

---

| | | | | |
|:---|:---|:---|:---|:---|
| *(Dollars in thousands)* | **March 31,<br>2026** | **December 31,<br>2025** | **$ Change** | **% Change** |
| Noninterest-bearing deposits | $243458 | $245377 | $(1919) | (0.8)% |
| Interest-bearing deposits: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest-bearing demand deposits | 157151 | 157360 | (209) | (0.1)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Money market and savings deposits | 1013533 | 1023290 | (9757) | (1.0)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Time deposits | 755818 | 732101 | 23717 | 3.2% |

---

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

---

| | | | | |
|:---|:---|:---|:---|:---|
| *(Dollars in thousands)* | **March 31,<br>2026** | **December 31,<br>2025** | **$ Change** | **% Change** |
| Noninterest-bearing deposits | $243458 | $245377 | $(1919) | (0.8)% |
| Total interest-bearing deposits | $1926502 | $1912751 | $13751 | 0.7% |
| Total deposits | $2169960 | $2158128 | $11832 | 0.5% |

---

Total deposits increased $11.8 million, or 0.5%, since December 31, 2025. Total interest-bearing deposits increased $13.8 million during the period, whereas noninterest-bearing deposits decreased $1.9 million. Time deposits increased $23.7 million, or 3.2%, largely due to customer preference for the higher interest rates offered by these products.

The majority of Meridian's deposit base is comprised of business deposits, 51%, with consumer deposits amounting to 15% at March 31, 2026. Municipal deposits at 11% and brokered deposits at 23% provide growth funding. Historically, business deposits lag loan fundings. A typical business relationship maintains operating accounts, investment accounts or sweep accounts and business owners may also have personal savings or wealth accounts. Deposit balances in business accounts have a tendency to be higher on average than consumer accounts. At March 31, 2026, 64% of business accounts and 89% of consumer accounts were fully insured by the FDIC. The municipal deposits are 100% collateralized and brokered deposits are 100% FDIC insured. The level of uninsured deposits for the entire deposit base was 20% at March 31, 2026.

**Capital**

Consolidated stockholders' equity of the Corporation was $200.2 million, or 7.8% of total assets as of March 31, 2026, as compared to $199.7 million, or 7.8% of total assets as of December 31, 2025. On April 23, 2026, the Board of Directors declared a quarterly cash dividend of $0.14 per common share payable May 11, 2026 to shareholders of record as of May 4, 2026.

On February 20, 2025 the Corporation entered into an Equity Distribution Agreement (or Sales Agreement) relating to shares of our common stock. During 2025 the Corporation sold a total of 488,478 shares of common stock and raised approximately $7.5 million in net proceeds. We expect to use the net proceeds for general corporate purposes, which includes working capital and the funding of organic growth at Meridian Bank, as described in our prospectus filed with the SEC on February 20, 2025 pursuant to Rule 424(b)(5) under the Securities Act. There were no shares of the Corporation's common stock sold during the three months ended March 31, 2026, or 2025, respectively.

Under the Community Bank Leverage Ratio framework, a community banking organization that is less than $10 billion in total consolidated assets, and has limited amounts of certain assets and off-balance sheet exposures, and a CBLR greater than 9% can elect to report a single regulatory capital ratio. The Corporation has elected to be measured under this framework for Bank capital adequacy and had ratios of 9.58% and 9.50% at March 31, 2026 and December 31, 2025, respectively. The Corporation is exempt from CBLR.

The following table presents the Bank's capital ratios and the minimum capital requirements to be considered "well capitalized" by regulators at the periods indicated:

---

| | | | |
|:---|:---|:---|:---|
| | **Bank** | **Bank** | **Well-capitalized minimum** |
| | **March 31,<br>2026** | **December 31,<br>2025** | **Well-capitalized minimum** |
| Tier 1 leverage ratio | 9.58% | 9.50% | 5.00% |
| Common tier 1 risk-based capital ratio | 10.52% | 10.66% | 6.50% |
| Tier 1 risk-based capital ratio | 10.52% | 10.66% | 8.00% |
| Total risk-based capital ratio | 11.51% | 11.65% | 10.00% |

---

In December 2018, the Federal Reserve announced that a banking organization that experiences a reduction in retained earnings due to the CECL adoption as of the beginning of the fiscal year in which CECL is adopted may elect to phase in the regulatory capital impact of adopting CECL. Transitional amounts are calculated for the following items: retained earnings, temporary difference deferred tax assets and credit loss allowances eligible for inclusion in regulatory capital. When calculating regulatory capital ratios, 25% of the transitional amounts are phased in during the first year. An additional 25% of the transitional amounts are phased in over each of the next two years and at the beginning of the fourth year, the day-one effects of CECL are completely reflected in regulatory capital. As of March 31, 2026, Meridian has phased in 100% of the day-one effects of CECL.

**Asset Quality Summary**

The ratio of non-performing assets to total assets was 2.51% as of March 31, 2026, compared to 2.38% reported as of December 31, 2025. Total non-performing loans of $58.7 million as of March 31, 2026, increased $3.6 million from $55.1 million as of December 31, 2025. Included in non-performing loans at March 31, 2026 is $12.9 million of SBA loan guarantees, while non-performing loans at December 31, 2025 included $13.2 million of SBA loan guarantees. The overall increase was primarily the result of risk rating downgrades leading to non-performing loan classification mainly in the commercial mortgage and construction portfolios, partially offset by a $870 thousand decline in non-performing SBA loans due to charge-offs. The increase in commercial mortgage non-performing

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

came largely from a purchased participation loan that is secured by a first lien on the leasehold interests of Class A office property with multiple buildings and tenants where an April 2026 appraisal, representative of conditions existing as of March 31, 2026, showed a significantly lower value than the original appraisal at the time of our participation. As of March 31, 2026 there were specific reserves of $2.8 million against non-performing loans, a decrease from $3.4 million as of December 31, 2025.

Meridian realized net charge-offs of 0.35% of total average loans for the three months ending March 31, 2026, which had increased from 0.14% reported for the same period in 2025. Net charge-offs for the quarter ended March 31, 2026 were $7.8 million, compared to net charge-offs of $2.8 million for the quarter ended March 31, 2025. Net charge-offs for the current quarter comprised of $8.2 million in total charge-offs, of which $3.9 million related to a commercial mortgage purchased participation and $2.5 million related to SBA. There were $407 thousand in recoveries during the period, largely related to leases.

The ratio of allowance for credit losses to total loans and other finance receivables, excluding loans at fair value (a non-GAAP measure, see reconciliation in the Appendix), was 0.98% as of March 31, 2026 compared to 1.00% as of December 31, 2025. Despite net charge-offs having increased as noted above, the level of provision for credit losses in the first quarter helped to maintain the allowance coverage level.

The Corporation believes it is proactive with its loan review process that utilizes the engagement of an independent outside loan review firm, which helps identify developing credit issues. For example, the Corporation procures additional collateral (preferably outside the current loan structure) whenever possible and frequent contact with the borrower. The Corporation believes that timely identification of credit issues and appropriate actions early in the process serve to mitigate overall risk of loss.

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

**Nonperforming Assets and Related Ratios**

The following table presents nonperforming assets and related ratios for the periods indicated:

---

| | | |
|:---|:---|:---|
| *(dollars in thousands)* | **March 31,<br>2026** | **December 31,<br>2025** |
| **Non-performing assets:** |  |  |
| Nonaccrual loans: |  |  |
| Real estate loans: |  |  |
| &nbsp;&nbsp;&nbsp;Commercial mortgage | $6748 | $2472 |
| &nbsp;&nbsp;&nbsp;Home equity lines and loans | 2223 | 2023 |
| &nbsp;&nbsp;&nbsp;Residential mortgage | 9350 | 10385 |
| &nbsp;&nbsp;&nbsp;Construction | 7688 | 6650 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total real estate loans | 26009 | 21530 |
| Commercial and industrial & other finance receivables | 7179 | 6770 |
| Small business loans <sup>(1)</sup> | 23911 | 24781 |
| Leases | 1560 | 1979 |
| Total nonaccrual loans | 58659 | 55060 |
| Other real estate owned | 3592 | 3592 |
| Repossessed assets | 2417 | 2405 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total non-performing assets | $64668 | $61057 |
| **Asset quality ratios:** |  |  |
| Non-performing assets to total assets | 2.51% | 2.38% |
| Non-performing loans to: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total loans and other finance receivables | 2.69% | 2.54% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total loans and other finance receivables (excluding loans at fair value) <sup>(2)</sup> | 2.71% | 2.55% |
| Allowance for credit losses to: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total loans and other finance receivables | 0.97% | 0.99% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total loans and other finance receivables (excluding loans at fair value) <sup>(2)</sup> | 0.98% | 1.00% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-performing loans | 36.23% | 39.18% |
| Total loans and leases | $2220535 | $2204362 |
| Total loans and other finance receivables | 2181575 | 2170600 |
| Total loans and other finance receivables (excluding loans at fair value) | 2167485 | 2156204 |
| Allowance for credit losses | 21252 | 21573 |

---

(1) Included in non-performing small business loans as of March 31, 2026 and December 31, 2025, respectively, are $12.9 million and $13.2 million in SBA guarantees.

(2) The allowance for credit losses to total loans and other finance receivables (excluding loans at fair value) ratio is a non-GAAP financial measure. See "Non-GAAP Financial Measures" for a reconciliation of this measure to its most comparable GAAP measure.

**Liquidity**

Management maintains liquidity to meet depositors' needs for funds, to satisfy or fund loan commitments, and for other operating purposes. Meridian's foundation for liquidity is a stable and loyal customer deposit base, cash and cash equivalents, and a marketable investment portfolio that provides periodic cash flow through regular maturities and amortization or that can be used as collateral to secure funding. In addition, as part of its liquidity management, Meridian maintains a portion of commercial loan assets that are comprised of SNCs, which have a national market and can be sold in a timely manner. Meridian's available liquidity, which totaled $348.0 million at March 31, 2026, compared to $346.3 million at December 31, 2025, includes investments, SNCs, Federal funds sold, mortgages held-for-sale and cash and cash equivalents, less the amount of securities required to be pledged for certain liabilities. Meridian also anticipates scheduled payments and prepayments on its loan and mortgage-backed securities portfolios.

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

In addition, Meridian maintains borrowing arrangements with various correspondent banks, the FHLB and the FRB to meet short-term liquidity needs and has access to approximately $744.9 million in liquidity from these sources. Through its relationship at the Federal Reserve, Meridian had available credit of approximately $4.3 million at March 31, 2026. At March 31, 2026, Meridian had $0 in borrowings from the Federal Reserve. As a member of the FHLB, Meridian is eligible to borrow up to a specific credit limit, which is determined by the amount of our residential mortgages, commercial mortgages and other loans that have been pledged as collateral. As of March 31, 2026, Meridian's maximum borrowing capacity with the FHLB was $732.0 million. At March 31, 2026, Meridian had borrowed $120.8 million and the FHLB had issued letters of credit, on Meridian's behalf, totaling $170.1 million against its available credit lines. At March 31, 2026, Meridian also had available $56.0 million of unsecured federal funds lines of credit with other financial institutions as well as $304.1 million of available short or long term wholesale funding arrangements through the CDARS/ICS one-way buy program and conventional brokered CDs. Management believes that Meridian has adequate resources to meet its short-term and long-term funding requirements.

**Discussion of Segments**

As of March 31, 2026, the Corporation has three principal segments as defined by FASB ASC 280, "*Segment Reporting."* The segments are Banking, Mortgage Banking and Wealth Management (see Note 10 in the accompanying Notes to Unaudited Consolidated Financial Statements).

The Banking Segment recorded income before tax of $3.0 million for the three months ended March 31, 2026, as compared to income before tax of $3.6 million for the same period in 2025. The Banking Segment provided 116.7% of the Corporation's pre-tax profit for the three months ended March 31, 2026, as compared to 116.0% for the same period in 2025.

The Wealth Management Segment recorded income before tax of $811 thousand for the three months ended March 31, 2026, as compared to income before tax of $726 thousand for the same period in 2025.

The Mortgage Banking Segment recorded a loss before tax of $1.2 million for the three months ended March 31, 2026, as compared to a loss before tax of $1.2 million for the same period in 2025. Mortgage Banking income and expenses related to loan originations and sales increased over the comparable periods due to higher loan origination and sales volume.

**Off Balance Sheet Risk**

The Corporation is a party to financial instruments with off-balance sheet risk in the normal course of business to meet the financing needs of its customers. These financial instruments include commitments to extend credit, standby letters of credit, and loan repurchase commitments.

Commitments to extend credit are agreements to lend to a customer as long as there is no violation of any condition established in the loan agreement. Total commitments to extend credit at March 31, 2026 were $656.1 million as compared to $641.9 million at December 31, 2025.

Standby letters of credit are conditional commitments issued by the Corporation to a customer for a third party. Such standby letters of credit are issued to support private borrowing arrangements. The credit risk involved in issuing standby letters of credit is similar to that involved in granting loan facilities to customers. The Corporation's obligation under standby letters of credit at March 31, 2026 amounted to $10.3 million as compared to $9.4 million at December 31, 2025.

Estimated fair values of the Corporation's off-balance sheet instruments are based on fees and rates currently charged to enter into similar loan agreements, taking into account the remaining terms of the agreements and the counterparties' credit standing. Since fees and rates charged for off-balance sheet items are at market levels when set, there is no material difference between the stated amount and the estimated fair value of off-balance sheet instruments.

In certain circumstances the Corporation may be required to repurchase residential mortgage loans from investors under the terms of loan sale agreements. Generally, these circumstances include the breach of representations and warranties made to investors regarding borrower default or early payment, as well as a violation of the applicable federal, state, or local lending laws. The Corporation agrees to repurchase loans if the representations and warranties made with respect to such loans are breached. Based on the obligations described above, the Corporation repurchased no loans for the three months ended March 31, 2026, and March 31, 2025, respectively.

**Non-GAAP Financial Measures**

Meridian believes that non-GAAP measures are meaningful because they reflect adjustments commonly made by management, investors, regulators and analysts to evaluate performance trends and the adequacy of common equity. This non-GAAP disclosure has limitations as an analytical tool, should not be viewed as a substitute for performance and financial condition measures determined in accordance with GAAP, and should not be considered in isolation or as a substitute for analysis of Meridian's results as reported under GAAP, nor is it necessarily comparable to non-GAAP performance measures that may be presented by other companies.

Our management used the measure of the tangible common equity ratio to assess our capital strength. We believe that this non-GAAP financial measure is useful to investors because, by removing the impact of our goodwill and other intangible assets, it allows investors to more easily assess our capital adequacy. This non-GAAP financial measure should not be considered a substitute for any regulatory capital ratios and may not be comparable to other similarly titled measures used by other companies.

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

The table below provides the non-GAAP reconciliation for our tangible common equity ratio and tangible book value per common share:

---

| | | |
|:---|:---|:---|
| *(dollars in thousands, except share data)* | **March 31,<br>2026** | **December 31,<br>2025** |
| Total stockholders' equity (GAAP) | $200225 | $199716 |
| Less: Goodwill and intangible assets | (3411) | (3462) |
| Tangible common equity (non-GAAP) | 196814 | 196254 |
| Total assets (GAAP) | 2576581 | 2561995 |
| Less: Goodwill and intangible assets | (3411) | (3462) |
| Tangible assets (non-GAAP) | $2573170 | $2558533 |
| Stockholders' equity to total assets (GAAP) | 7.77% | 7.80% |
| Tangible common equity to tangible assets (non-GAAP) | 7.65% | 7.67% |
| Shares outstanding | 11879 | 11826 |
| Book value per share (GAAP) | $16.86 | $16.89 |
| Tangible book value per share (non-GAAP) | $16.57 | $16.59 |

---

The following is a reconciliation of the allowance for credit losses to total loans held for investment ratio at March 31, 2026 and December 31, 2025. This is considered a non-GAAP measure as the calculation excludes the impact of loans held for investment that are fair valued as these loan types are not included in the allowance for credit losses calculation.

---

| | | |
|:---|:---|:---|
| *(dollars in thousands)* | **March 31,<br>2026** | **December 31,<br>2025** |
| Allowance for credit losses (GAAP) | $21252 | $21573 |
| Loans and other finance receivables (GAAP) | 2181575 | 2170600 |
| Less: Loans at fair value | (14090) | (14396) |
| Loans and other finance receivables, excluding loans at fair value (non-GAAP) | $2167485 | $2156204 |
| Allowance for credit losses to loans and other finance receivables (GAAP) | 0.97% | 0.99% |
| Allowance for credit losses to loans and other finance receivables, excluding loans at fair value (non-GAAP) | 0.98% | 1.00% |

---

The following is a reconciliation of non-performing loans, excluding the guaranteed portion of SBA loans that are classified as non-performing loans, to total loans and leases at March 31, 2026 and December 31, 2025. This is considered a non-GAAP measure as the calculation excludes the impact of SBA guarantees from non-performing loans.

---

| | | |
|:---|:---|:---|
| *(dollars in thousands)* | **March 31,<br>2026** | **December 31,<br>2025** |
| Non-performing loans (GAAP) | $58659 | $55060 |
| Less: Guaranteed portion of SBA loans classified as non-performing | (12906) | (13177) |
| Non-performing loans, excluding guaranteed portion of SBA loans (non-GAAP) | $45753 | $41883 |
| Total loans and leases | $2220535 | $2204362 |
| Non-performing loans (excluding guaranteed portion of SBA loans) to total loans and leases | 2.06% | 1.90% |

---

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

**Item 3. Quantitative and Qualitative Disclosures About Market Risk.**

**Simulations of Net Interest Income**

We use a simulation model on a quarterly basis to measure and evaluate potential changes in our net interest income resulting from various hypothetical interest rate scenarios. Our model incorporates various assumptions that management believes to be reasonable, but which may have a significant impact on results such as:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the timing of changes in interest rates;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• shifts or rotations in the yield curve;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• repricing characteristics for market rate sensitive instruments on the balance sheet;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• differing sensitivities of financial instruments due to differing underlying rate indices;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• varying timing of loan prepayments for different interest rate scenarios;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the effect of interest rate floors, periodic loan caps and lifetime loan caps; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• overall growth rates and product mix of interest-earning assets and interest-bearing liabilities.

Because of the limitations inherent in any approach used to measure interest rate risk, simulated results are not intended to be used as a forecast of the actual effect of a change in market interest rates on our results, but rather as a means to better plan and execute appropriate ALM strategies.

Potential increase (decrease) to our net interest income between a flat interest rate scenario and hypothetical rising and declining interest rate scenarios, measured over a one-year period as of the dates indicated, are presented in the following table which assuming rate shifts occur upward and downward on the yield curve in even increments over the first twelve months (ramp) followed by rates held constant thereafter.

---

| | | |
|:---|:---|:---|
| | **March 31,** | **March 31,** |
| **Changes in Market Interest Rates** | **2026** | **2025** |
| +300 basis points over next 12 months | 1.39% | 2.10% |
| +200 basis points over next 12 months | 1.00% | 1.61% |
| +100 basis points over next 12 months | 0.53% | 0.94% |
| No Change |  |  |
| -100 basis points over next 12 months | (1.18)% | (1.12)% |
| -200 basis points over next 12 months | (1.89)% | (2.05)% |
| -300 basis points over next 12 months | (2.50)% | (1.89)% |

---

The above interest rate simulation suggests as of March 31, 2026 that the Corporation's balance sheet is fairly neutrally positioned over the next 12 months. The simulated exposure to a change in interest rates is manageable and well within policy guidelines. The results continue to drive our funding strategy of increasing relationship-based accounts (core deposits) and utilizing term deposits to fund short to medium duration assets.

**Simulation of economic value of equity**

To quantify the amount of capital required to absorb potential losses in value of our interest-earning assets and interest-bearing liabilities resulting from adverse market movements, we calculate economic value of equity on a quarterly basis. We define economic value of equity as the net present value of our balance sheet's cash flow, and we calculate economic value of equity by discounting anticipated principal and interest cash flows under the prevailing and hypothetical interest rate environments. Potential changes to our economic value of equity between a flat rate scenario and hypothetical rising and declining rate scenarios are presented in the following table. The projections assume shifts upward and downward in the yield curve of 100, 200 and 300 basis points occurring immediately.

---

| | | |
|:---|:---|:---|
| | **March 31,** | **March 31,** |
| **Changes in Market Interest Rates** | **2026** | **2025** |
| +300 basis points | 7% | 10% |
| +200 basis points | 6% | 9% |
| +100 basis points | 4% | 5% |
| No Change |  |  |
| -100 basis points | (7)% | (9)% |
| -200 basis points | (18)% | (22)% |
| -300 basis points | (35)% | (43)% |

---

This economic value of equity profile at March 31, 2026 suggests that an instantaneous decrease in rates would have a negative impact on value of the Banks' balance sheet. While an instantaneous shift in interest rates is used in this analysis to provide an estimate of

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

exposure, we believe that a gradual shift in interest rates would have a much more modest impact. Since economic value of equity measures the discounted present value of cash flows over the estimated lives of instruments, the change in economic value of equity does not directly correlate to the degree that earnings would be impacted over a shorter time horizon.

The results of our net interest income and economic value of equity simulation analysis are purely hypothetical, and a variety of factors might cause actual results to differ substantially from what is depicted. For example, if the timing and magnitude of interest rate changes differ from that projected, our net interest income might vary significantly. Non-parallel yield curve shifts or changes in interest rate spreads would also cause net interest income to be different from that projected. An increasing interest rate environment could reduce projected net interest income if deposits and other short-term interest-bearing liabilities reprice faster than expected or faster than our interest-earning assets. Actual results could differ from those projected if interest-earning assets and interest-bearing liabilities grow faster or slower than estimated, or otherwise change its mix of products. Actual results could also differ from those projected if actual repayment speeds in the loan portfolio are substantially different than those assumed in the simulation model. Furthermore, the results do not take into account the impact of changes in loan prepayment rates on loan discount accretion. If loan prepayment rates were to increase, any remaining loan discounts would be recognized into interest income. This would result in a current period offset to declining net interest income caused by higher rate loans prepaying. Finally, these simulation results do not contemplate all the actions that management may undertake in response to changes in interest rates, such as changes to loan, investment, deposit, funding or other strategies.

Management has and continues to employ strategies to mitigate risk in the Net Interest Income and Economic Value simulations.

**Item 4. Controls and Procedures**

**Evaluation of Disclosure Controls and Procedures**

Our management, with the participation of our CEO and CFO, has evaluated the effectiveness of our disclosure controls and procedures as defined in Rules 13a- 15(e) and 15d- 15(e) under the Exchange Act, as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, the Corporation's CEO and CFO have concluded that the Corporation's disclosure controls and procedures were effective as of March 31, 2026 to ensure that the information required to be disclosed by the Corporation in the reports that the Corporation files or submits under the Exchange Act is recorded, processed, summarized, and reported completely and accurately within the time periods specified in SEC rules and forms.

**Changes in Internal Control Over Financial Reporting**

There was no change in the Corporation's internal control over financial reporting identified during the quarter ended March 31, 2026 that has materially affected, or is reasonably likely to materially affect, the Corporation's internal control over financial reporting.

**PART II–OTHER INFORMATION**

**Item 1. Legal Proceedings.**

None

**Item 1A. Risk Factors.**

None

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.**

None

**Item 3. Defaults upon Senior Securities.**

None

**Item 4. Mine Safety Disclosures.**

Not applicable

**Item 5. Other Information.**

None

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

**Item 6. Exhibits.**

**EXHIBIT INDEX**

---

| | |
|:---|:---|
| Exhibit<br>Number | **Description** |
| 3.1 | <u>[Amended Articles of Incorporation of Registrant, filed as Exhibit 3.1 to Form 10-Q on August 16, 2021 and incorporated herein by reference.](https://www.sec.gov/Archives/edgar/data/1750735/000155837021011811/mrbk-20210630xex3d1.htm)</u> |
| 3.2 | <u>[Bylaws of Registrant, filed as Exhibit 3.2 to Form 8-K on August 24, 2018 and incorporated herein by reference.](https://www.sec.gov/Archives/edgar/data/1750735/000110465918053558/a18-21125_1ex3d2.htm)</u> |
| 31.1 | <u>[Rule 13a-14(a)/ 15d-14(a) Certification of the Principal Executive Officer, filed herewith.](mrbk_ex31x1x3312026.htm)</u> |
| 31.2 | <u>[Rule 13a-14(a)/ 15d-14(a) Certification of the Principal Financial Officer, filed herewith.](mrbk_ex31x2x3312026.htm)</u> |
| 32 | <u>[Section 1350 Certifications, filed herewith.](mrbk_ex32x3312026.htm)</u> |
| 101.INS | XBRL Instance Document – The instance document does not appear in the interactive Data File because its XBRL tags are embedded within the Inline XBRL document |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| Exhibit 104 | Cover Page Interactive Data File – The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document |

---

------

<u>[**Table of Contents**](#i35a1119feabe45df9d3857a088023686_7)</u>

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
| Date: | May 11, 2026 | Meridian Corporation | Meridian Corporation |
|  |  | By: | /s/ Christopher J. Annas |
|  |  |  | Christopher J. Annas<br>President and Chief Executive Officer<br>(Principal Executive Officer) |
|  |  | By: | /s/ Denise Lindsay |
|  |  |  | Denise Lindsay<br>Executive Vice President and Chief Financial Officer<br>(Principal Financial and Accounting Officer) |

---

## Exhibit 31.1

**Exhibit 31.1**

**RULE 13a -14(a) CERTIFICATION<br>OF THE PRINCIPAL EXECUTIVE OFFICER**

I, Christopher J. Annas, certify that:

1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; I have reviewed this Quarterly Report on Form 10-Q of Meridian Corporation;

2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting;

5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: May 11, 2026 | /s/ Christopher J. Annas |
| | Christopher J. Annas |
| | President and Chief Executive Officer |
| | (Principal Executive Officer) |

---

## Exhibit 31.2

**Exhibit 31.2**

**RULE 13a-14(a) CERTIFICATION<br>OF THE PRINCIPAL FINANCIAL OFFICER**

I, Denise Lindsay, certify that:

1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; I have reviewed this Quarterly Report on Form 10-Q of Meridian Corporation;

2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting;

5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: May 11, 2026 | /s/ Denise Lindsay |
| | Denise Lindsay |
| | Executive Vice President and Chief Financial Officer |
| | (Principal Financial and Accounting Officer) |

---

## Ex-32

**Exhibit 32**

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO<br>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of Meridian Corporation on Form 10-Q for the period ended March 31, 2026 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Meridian Corporation.

---

| | |
|:---|:---|
| | /s/ Christopher J. Annas |
| | Christopher J. Annas |
| | President and Chief Executive Officer |
| | (Principal Executive Officer) |
| | /s/ Denise Lindsay |
| | Denise Lindsay |
| | Executive Vice President and Chief Financial Officer |
| | (Principal Financial and Accounting Officer) |
| Date:&nbsp;&nbsp;&nbsp;&nbsp;May 11, 2026 | |

---

<br>